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Abstract 
The age-related loss of skeletal muscle mass and function that is associated with sarcopenia 
can result in ultimate consequences such as decreased quality of life. The causes of sarcopenia 
are multifactorial and include environmental and biological factors. The purpose of this review 
is to synthesize what the literature reveals in regards to the cellular regulation of sarcopenia, 
including impaired muscle regenerative capacity in the aged, and to discuss if physiological 
stimuli have the potential to slow the loss of myogenic potential that is associated with 
sarcopenia. In addition, this review article will discuss the effect of aging on Notch and Wnt 
signaling, and whether physiological stimuli have the ability to restore Notch and Wnt sig-
naling resulting in rejuvenated aged muscle repair. The intention of this summary is to bring 
awareness to the benefits of consistent physiological stimulus (exercise) to combating sar-
copenia as well as proclaiming the usefulness of contraction-induced injury models to studying 
the effects of local and systemic influences on aged myogenic capability. 
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Introduction 
With aging there is a decline in the function of 
multiple organ systems including heart, brain, nerves, 
blood,  skin  and  skeletal  muscle.  Sarcopenia  is  the 
age-associated  loss  of  muscle  mass  and  function, 
which may appear as early as 50 years (y) in humans 
(1).  The  prevalence  of  sarcopenia  greatly  increases 
over the age of 80 y with reports of 50% or greater loss 
of muscle strength (2, 3).  
The causes of sarcopenia appear to be multifac-
torial  and  include  hormones,  sedentary  lifestyle, 
smoking, genetics, body size and composition. How-
ever, the cellular aspects of age-associated sarcopenia 
are  not  well  elucidated.  Because  people  are  living 
longer,  understanding  the  mechanisms  underlying 
sarcopenia is critical to the development of therapeu-
tic  and  prevention  strategies  that  will  decrease  sar-
copenia-associated  morbidity  and  mortality  in  the 
aging population. 
A contributing factor to sarcopenia is a dimin-
ished ability of aged muscle to repair itself following 
injury (4-8). There are multiple suggested mechanisms 
for the impaired muscle regenerative process in aged 
muscle including loss of satellite cell number or func-
tion,  decreased  myoblast  proliferation  or  weakened 
differentiation  states.  However,  more  studies  are 
needed  before  a  definitive  answer  can  be  reached. 
Although  satellite  cell  activity  is  rigorous  during 
muscle formation in the young, with age there is an 
attrition in satellite cell function (5, 7, 9-11). The novel 
finding that impaired Notch signaling may be partly 
responsible for the loss of myogenic potential in aged 
muscle  is  intriguing,  and  provides  a  potential  clue 
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into the mechanisms underlying sarcopenia (7, 12, 13). 
In addition, there may be a dysfunctional orchestra-
tion of the signaling pathways, Notch and Wnt that 
result in impaired muscle repair in the aged (14-17). 
The coordination of these signaling pathways during 
postnatal myogenesis is not well defined, nor is their 
contribution to impaired myogenic potential in aged 
muscle. 
Physiological stimuli (exercise, injurious muscle 
contractions, hypertrophy models) are known to in-
crease  Notch  and  Wnt  signaling  in  young  muscle 
(18-23). However, little is known about the influence 
of physiological stimuli on the expression and coor-
dination  of  Notch  and  Wnt  signaling  in  repairing 
aged  muscle.  Studying  the  effect  of  physiological 
stimuli  on  Notch  and  Wnt  coordination  during  the 
regenerative process of aged muscle may lead to an 
effective interventional strategy for sarcopenia. Con-
sequently,  such  studies  deserve  further  exploration. 
The purpose of this review is to examine the cellular 
regulation of sarcopenia, including impaired muscle 
regenerative  capacity  in  the  aged,  and  to  discuss  if 
physiological stimuli have the potential to slow the 
loss  of  myogenic  potential  that  is  associated  with 
sarcopenia. In addition, this review article will discuss 
the effect of aging on Notch and Wnt signaling, and 
whether physiological stimuli have the ability to re-
store  Notch  and  Wnt  signaling  resulting  in  rejuve-
nated aged muscle repair. A better understanding of 
these issues may lead to novel therapeutic strategies 
to prevent the loss of muscle quality seen in sarcope-
nia. 
Impact of sarcopenia 
Sarcopenia (also called senile muscle atrophy) is 
an age-related loss of skeletal muscle mass and func-
tion that is often determined by measuring the skele-
tal mass index (24). The percentage of skeletal muscle 
index is calculated by dividing muscle mass by the 
squared height, or by dividing muscle mass by body 
mass (24, 25). Sarcopenia is experienced primarily in 
the  lower  extremities,  which  may  be  related  to  re-
duced physical activity with age, or to greater loss of 
motor units in the legs than arms (25, 26). Evidence 
suggests that the age-related loss of muscle mass is 
the  cause  of  poor  strength,  yet  the  impairment  of 
muscle strength and power (dynapenia) is more pro-
found than the loss of muscle mass (27). 
There is a dichotomy in the relationship between 
age-associated mortality and sarcopenia. The negative 
attributes associated with aging including poor nutri-
tion, sedentary lifestyle, pain associated with range of 
motion, as well as the degenerative cellular manifes-
tations cause an inability to use the vital organ, skel-
etal muscle resulting in muscle atrophy. With the loss 
of muscle mass, there is an inability to perform activi-
ties  of  daily  living  which  exacerbates  the  loss  of 
strength, leading to disabilities, nursing home admis-
sions  and  ultimately  increased  mortality  (28).  This 
review  article  will  discuss  the  variety  of  manifesta-
tions  associated  with  aging  that  cause  sarcopenia. 
Sarcopenia exerts its effects on other systems and in-
clude,  but  are  not  limited  to:  cardiovascular,  meta-
bolic, and bone (1, 29, 30). Since skeletal muscle is a 
component  of  cardiorespiratory  fitness, 
age-associated skeletal muscle atrophy results in poor 
oxyten uptake by skeletal muscle and sedentary life-
style  weakens  cardiovascular  function.  In  addition, 
there  is  impaired  oxidative  metabolism  in  atrophic 
skeletal muscle, resulting in poor glucose regulation 
and metabolic disease. Abnormal gait and disabilities 
ensues with muscle atrophy and sedentary lifestyle as 
well  as  the  bone  disease  osteoporosis  (mus-
cle-associated force applied to the bone is needed for 
good health fitness) (1, 29, 30). Sarcopenia negatively 
influence  other  organs  whose  destructive  outcomes 
result  in  loss  of  independence,  and  ultimately  in-
creased morbidity (1, 30).  
Causes of sarcopenia 
There are a variety of factors that contribute to 
sarcopenia,  including  both  environmental  and  bio-
logical  factors.  For  example,  poor  nutrition  and  a 
sedentary lifestyle are contributors to sarcopenia (2, 
29). The loss of appetite that afflicts many elderly in-
dividuals leads to decreased food intake and Vitamin 
D and protein deficiencies. This may impair protein 
synthesis and ultimately decrease muscle mass (2, 29). 
Edstrom et al. suggest that dietary intervention may 
be a tool to combat sarcopenia (26). In addition to loss 
of appetite, many elderly individuals suffer from or-
thopedic pathologies, and associate movement with 
pain, resulting in decreased physical activity and ul-
timately loss of muscle mass and strength (30). How-
ever, elderly individuals who are highly active (such 
as Masters Athletes) also have significantly less mus-
cle mass than their younger counterparts, suggesting 
that disuse may not be the sole contributor to sarco-
penia (30, 31). Thus, other age-related causes of sar-
copenia, besides an increased sedentary lifestyle, need 
to  be  delineated  (25).  Although  lifestyle  is  an  im-
portant player in the development of sarcopenia, the 
majority of contributors to age-related loss of muscle 
efficiency involve multiple biological systems such as: 
central  and  peripheral  nervous  systems,  endocrine, 
immune, and metabolic systems (8, 25, 28-30, 32, 33). 
This review will discuss what are thought to be the 
major contributing factors underlying the physiolog-Int. J. Biol. Sci. 2012, 8 
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ical manifestations of sarcopenia.  
I. Molecular and Cellular Manifestations asso-
ciated with Sarcopenia 
a. Increased intramuscular fibrosis and adipose 
tissue: The tissue composition of sarcopenic skeletal 
muscle is altered and consists predominately of con-
nective and adipose tissue, a condition  termed my-
osteatosis (25, 28). In obese aged individuals, this oc-
currence is termed “Sarcopenic Obesity” (25, 28). In-
creased fibrosis within the sarcopenic muscle may be 
related to elevated extracellular matrix protein (col-
lagen)  levels,  as  well  as  the  accumulation  of  debris 
from  impaired  protein  degradation  (14,  26,  34).  In 
addition,  there  is  greater  fibronectin  expression  in 
aged myofiber explants compared to young myofiber 
explants (14).  
b. Increased pro-inflammatory cytokines TNFα 
and IL-6: Aging is associated with a state of chronic, 
low  inflammation.  There  are  many  reports  of 
increased  levels  of  the  pro-inflammatory  cytokines 
tumor  necrosis  factor  α  (TNFα)  and  interleukin-  6 
(IL-6) in the systemic circulation of the elderly (35-42). 
For example, there was a 2.8 fold increase in TNFα 
expression in skeletal muscle of aged (~ 70 y) male 
subjects compared to young (~20 y) male subjects (38). 
Phillips  et al.  also  reported  increased  expression  of 
TNFα in soleus and vastus lateralis (VL) of aged (26 
month (mo)) rats relative to young (6 mo) rats (39). 
Furthermore, centurions were found to have signifi-
cantly higher plasma TNFα levels than younger (18 – 
30 y) controls with corresponding elevations of IL-6 
(37). Studies report a link between elevated plasma 
IL-6 with age and increased mortality  (40-42). Rou-
benoff et al. reported increased plasma levels of IL-6 in 
aged (~ 79 y) subjects relative to young (~ 39 y) con-
trols.  However,  there  was  no  difference  in  plasma 
TNFα levels between the age groups (42). High levels 
of IL-6 and TNFα are associated with a multitude of 
age-related diseases including obesity, cardiovascular 
diseases, type II diabetes and sarcopenia (35, 36, 43). It 
should be noted however, that some reports have not 
found  differences  in  plasma  and  skeletal  muscle 
TNFα or IL-6 levels between young and aged models; 
but rather suggest that the aged environment may be 
more  sensitive  to  the  effects  of  these 
pro-inflammatory cytokines (36). 
Although the mechanism for the potential eleva-
tion of TNFα and IL-6 with age, and the relationship 
of these cytokines to sarcopenia are not well defined, 
they  may  be  related  to  increased  levels  of  adipose 
tissue in the elderly (1, 30). Adipocytes secrete IL-6 
and TNFα as well as the adipokines leptin and adi-
ponectin,  which  promote  inflammation. 
Pro-inflammatory  cytokines  and  adipokines  deter 
muscle mass formation and promote fat mass accu-
mulation (28, 29). Elevated TNFα in aged muscle is 
associated  with  decreased  muscle  force  production 
(44, 45). TNFα is also linked to sarcopenia because this 
pro-inflammatory cytokine is known to be associated 
with  other  factors  that  contribute  to  sarcopenia  in-
cluding protein degradation, reactive oxygen species 
(ROS) accumulation and apoptosis (35, 46). In addi-
tion,  TNFα  may  be  associated  with  sarcopenia  by 
promoting insulin resistance, delaying muscle repair, 
and exacerbating the pro-inflammatory response by 
up-regulating IL-6 (25, 43, 45-47). 
Because  IL-6  has  both  pro-  and  an-
ti-inflammatory  characteristics  and  has  effects  on 
muscle growth and atrophy, it is difficult to discern 
the  role  of  IL-6  in  the  development  of  sarcopenia. 
There is a negative correlation between IL-6 and skel-
etal  muscle  strength  in  the  elderly,  and 
over-expression of IL-6 is associated with muscle at-
rophy  (48,  49)  IL-6  may  contribute  to  insulin  re-
sistance  and  inhibit  insulin-like  growth  factor-1 
(IGF-1), which promotes protein degradation during 
sarcopenia (47, 50). Inhibiting IL-6 with an antibody 
or an anti-inflammatory reagent results in increased 
protein synthesis and a rescue of the loss of muscle 
mass (51, 52). Additional research is needed to delin-
eate the relationship and contribution of TNFα and 
IL-6 to sarcopenia. 
c. Decreased sex hormones: As one ages, there is 
a  direct  correlation  between  the  levels  of  sex 
hormones and muscle mass suggesting that depletion 
of  testosterone  and  estrogen  may  contribute  to 
sarcopenia (1, 8). In addition, it is suggested that the 
age-associated  decline  in  estrogen  and  testosterone 
are  related  to  increases  in  levels  of  the 
pro-inflammatory  cytokines  IL-6  and  TNF,  which 
may accelerate the loss of muscle mass during sarco-
penia (8, 53, 54). With aging, there is also a correlation 
between decreased sex hormone levels and a decline 
in the growth factors of growth hormone (GH) and 
IGF-1, which may contribute to sarcopenia  (54, 55). 
Postmenopausal (58-70 y) women possess lower GH 
levels than premenopausal (45-51 y) women, and the 
lack  of  GH  is  known  to  promote  intramuscular  fat 
accumulation  and  loss  of  muscle  mass  (8,  55).  Fer-
rando et al. report that aged (> 60 y) men who were 
administered testosterone therapy showed increased 
IGF-1 protein levels (56).  
Between the age ranges of young (20 – 29 y) and 
aged (70 – 84 y), bioavailable testosterone drops ~ 4.2 
fold  and  the  testosterone  precursor  dehydroepi-
androsterone (DHEA) falls ~ 67 fold (57). Between the 
ages of 70 and 102 years, testosterone levels decrease Int. J. Biol. Sci. 2012, 8 
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with a corresponding decline in muscle strength, and 
with testosterone supplementation, there is a rescue of 
muscle mass and function (56-60). Ferrando et al. re-
ported  that  aged  (>  60  y)  male  subjects  who  were 
administered testosterone supplementation for 6 mo 
experienced gains in leg and arm muscle strength as 
well as increased muscle protein synthesis (56). Sin-
ha-Hikim  et  al.  reported  similar  findings  in  which 
aged (60-75 y) males who were administered testos-
terone  enanthate  for  20  weeks  (wk)  displayed  in-
creased  cross  sectional  area  of  VL  muscle  and  in-
creased  expression  of  markers  of  myogenicity  (58). 
Furthermore, aged (22 mo) mice given a testosterone 
implant for 2  mo experienced diminished  oxidative 
stress and myostatin levels, as well as increased my-
ogenicity (60). These data show that testosterone cor-
relates with sarcopenia, muscle mass and function as 
well  protein  synthesis  function.  Consequently,  re-
storing  testosterone  levels  in  aged  skeletal  muscle 
may  be  favorable  for  the  prevention  or  reversal  of 
sarcopenia. 
The decline in expression of estrogen in women 
that contributes to menopause (average age of onset is 
51.4 y) (57) is associated with sarcopenia (8, 61). Loss 
of estrogen may promote body composition changes, 
including a loss of muscle mass, but an increase in 
adipose tissue as well as a redistribution of body fat to 
the visceral region (54, 61, 62). Maltais et al. suggests 
that  estrogen  may  prevent  fat  accumulation  within 
skeletal  muscle  and  may  have  a  direct  relationship 
with lipoprotein lipase (which catalyzes triglyceride 
utilization).  Thus,  increased  intramuscular  fat  in 
postmenopausal  women  may  be  related  in  part  to 
deceased estrogen levels. Decreased muscle strength 
correlates  with  the  age-associated  loss  of  estrogen 
(54).  Replacing  estrogen  levels  with  hormone  re-
placement therapy (HRT) to increase muscle mass and 
strength is controversial (61, 63). Some reports show 
that HRT increases muscle mass and strength (61, 62). 
Taking HRT for one year resulted in increased quad-
riceps  cross  sectional  area  (6.3%)  and  decreased 
quadriceps  intramuscular  fat  (4.9%)  (61).  However, 
there  are  studies  that  suggest  HRT  may  not  be  an 
ideal tool for sarcopenia as there were no changes in 
muscle mass or strength with HRT and there are re-
ports of significant negative consequences associated 
with HRT such as increased risks of cancer and car-
diovascular  diseases  including  stroke  (54,  63-65). 
Rossouw et al. report a 26% and 37% increase in inva-
sive breast cancer and colorectal cancer respectively 
(65). It is interesting to note that women over the age 
of 65 who were on estrogen replacement therapy for 
three years did not experience any changes in body fat 
percentage  or  physical  performance  (64).  The 
age-associated  loss  of  sex  hormones  contributes  to 
sarcopenia directly, but also influences other factors 
that exacerbate the loss of muscle mass and function 
and the accumulation of intramuscular adipose tissue. 
Thus although the decline of sex hormone levels with 
aging  contributes  to  sarcopenia,  straightforward  re-
placement  of  under-produced  estrogen  or  testos-
terone  may  not  be  the  most  successful  treatment 
strategy  because  these  hormones  also  interact  with 
other systems (inflammation, growth factors). 
d. Alterations to muscle fibers and motor units: 
Both muscle fiber loss and decrease in skeletal muscle 
cross-sectional  area  are  associated  with  sarcopenia 
(66). There is a switch of muscle fiber types from type 
II to type I, and a greater loss of type II muscle fibers 
than type I in aged skeletal muscle (25, 31, 67, 68). The 
VL of aged (~ 68 y) men had a higher percentage of 
fibers expressing Myosin heavy chain (MHC) type I (~ 
20%) relative to VL of young (~ 28 y) subjects (~ 8%) 
(31).  In  addition  to  the  loss  of  muscle  fibers  is  an 
age-associated remodeling of the muscle architecture 
in which the muscle fiber fascicle length and the in-
sertion angle decreases and there is a loss of sarco-
meres (69). Multiple mechanisms appear to underlie 
the structural alteration of the skeletal muscle archi-
tecture, including a decreased rate of protein synthe-
sis within the aged muscle. These changes ultimately 
result in decreased aged muscle force production (25).  
Motor  unit  alterations  may  be  a  contributing 
factor to the age-associated loss of Type II muscle fi-
bers (70). These motor unit alterations include a de-
crease in firing frequency and motor unit recruitment, 
loss of Type II motor units and a reduced number of 
motoneurons  innervating  muscle  fibers,  especially 
Type II muscle fibers which are then more susceptible 
to muscle atrophy and possibly sarcopenia (66, 71-73). 
Accelerated denervation may be related to elevated 
oxidative  stress  and  accumulation  of  dysfunctional 
protein  machinery  at  the  neuromuscular  junction 
within aged skeletal muscle (74). Using electron mi-
croscopy images to study the neuromuscular junction 
(NMJ)  structure,  superoxide  dismutase  knockout 
transgenic mice displayed greater NMJ degeneration 
with  dysfunctional  mitochondrial  activity  in  close 
proximity as well as decreased contractile force pro-
duction  relative  to  wild  type,  suggesting  impaired 
neuromuscular  junction  contributes  to  sarcopenia 
(75). In addition, there is decreased presence of ciliary 
neurotrophic factor and vascular endothelial growth 
factor, both of which are important for motorneuron 
stability  (25).  Remaining  denervated  muscle  fibers 
attempt to compensate by re-innervating the surviv-
ing motor units, which consequently change the fiber 
type to slow-twitch (Type I). However the accelerated Int. J. Biol. Sci. 2012, 8 
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rate of denervation is faster than the decreased rate of 
reinnervation, resulting in loss of muscle function (25, 
30, 66, 73, 75). Some suggest that degeneration within 
the neuromuscular system may be the greatest con-
tributing  factor  to  sarcopenia,  while  others  contend 
that the muscle fiber denervation plays only a minor 
role (26, 76). Edstrom et al. reports that there is insig-
nificant motorneuron loss during aging and suggests 
that impaired reinnervation of the myofiber is a cause 
of poor muscle regenerative response and sarcopenia 
rather than motorneuron denervation (Edstrom #26). 
Although  correlations  of  motorneuron  degeneration 
and sarcopenia are reported, more research is needed 
to  provide  compelling  evidence  that  motorneuron 
degeneration is a major player in the development of 
sarcopenia. Potential studies could include testing if 
reinnervation  is  the  limiting  factor  by  comparing 
markers of sarcopenia in denervated muscle that was 
exposed  to  the  microenvironment  that  promotes 
reinnervation or a microniche that inhibits reinnerva-
tion.  
e.  Protein  synthesis/degradation  imbalance:  A 
disruption of the balance between protein synthesis 
and protein degradation, resulting in the accumula-
tion of damaged proteins, is also associated with ag-
ing skeletal muscle and sarcopenia (1, 77, 78). There is 
increased  protein  modification  with  aging  possibly 
related  to  oxidative  stress  (78).  Exacerbating  the 
problem is the fact that the primary pathways used to 
remove  modified  proteins  (proteasome  system,  au-
tophagy and lysosomal degradation) are less active in 
aged muscle (1, 78, 79). For example, in the lysosomal 
pathway in aged muscle, there is diminished delivery 
of membrane proteins or organelles to the lysosome 
and fusion of vacuoles with lysosomes (79). The attri-
tion  of  protein  degradation  pathways  results  in 
accumulation of damaged proteins. 
The rate of protein synthesis in aged muscle is 
reduced, with reports of decreased myofibrillar pro-
tein content and MHC expression (77, 78). There are 
multiple causes of decreased protein synthesis in aged 
skeletal muscle, such as underproduction of circulat-
ing and tissue-associated GH and IGF-1 isoforms (80, 
81). Low levels of IGF-1 in aged muscle is related to 
high expression of muscle growth inhibitors including 
the pro-inflammatory cytokines TNF and IL-6 (2, 38, 
73, 82). In skeletal muscle of aged (70 y) subjects, there 
is a 45% decrease in growth hormone receptor protein 
(GHR)  and  IGF-1  mRNA,  along  with  a  2.8  fold  in-
crease in TNF mRNA relative to young (20 y) sub-
jects (38). Aged women with lower IGF-1 levels and 
greater IL-6 expression relative to younger counter-
parts, demonstrate aspects of disability and increased 
mortality (28, 83). This opposing relationship between 
IGF-1 and the cytokines TNFα and IL-6 are considered 
indicators for sarcopenia (83). 
 f. Decreased IGF-1 and mRNA translation: The 
decreased presence of IGF-1 in aged skeletal muscle 
may contribute to sarcopenia by severely impacting 
protein synthesis. IGF-1 has anabolic effects on mus-
cle protein content by inhibiting protein degradation 
and promoting myogenesis. Thus, IGF-1 attrition in 
aged  skeletal  muscle  is  associated  with  less  protein 
synthesis and muscle growth (84, 85). In the presence 
of  IGF-1,  aged  (25  mo)  rats  increased  total  protein 
content by 27% in gastrconemius muscle relative to 
control (84). In addition, there was increased muscle 
mass and force production in mdx mice (mouse model 
that represents  Duchenne  muscular dystrophy)  that 
were  treated  with  IGF-1  (86,  87).  Injection  of  an 
adeno-virus with overexpressed IGF-IEa into aged (27 
mo)  mice  resulted  in  increased  muscle  mass  and 
strength (88). IGF-1 administration to the aged skele-
tal muscle may negate the impaired protein synthesis 
observed in sarcopenia. 
A reduction in IGF-1 may also influence protein 
synthesis  in  aged  skeletal  muscle  via  inefficient 
mRNA translation (79, 89-92). The mammalian target 
of rapamycin (mTOR) signaling pathway is important 
for  translation  initiation  and  is  therefore  critical  for 
muscle protein synthesis.  One mechanism that acti-
vates  mTOR  signaling  is  the 
IGF-1/PI3k/serine/threonine  kinase  (Akt)  pathway. 
Downstream  effectors  of  mTOR  signaling  include 
70-kilodalton  ribosomal  S6  protein  kinase  (p70s6k), 
eukaryotic  translation  initiation  factor  4E  binding 
protein  1  (4E-BP-1),  eukaryotic  translation  initiation 
factor  4E  (eIF-4E),  and  ribosomal  protein  S6  kinase 
(S6K1).  Aged  rodent  muscles  have  reduced  mTOR 
(Akt phosphorylation) and p70s6k signaling (89-93). 
Paturi et al. reported that aged (36 mo) mouse soleus 
had less Akt (and phosphorylated Akt), p70s6k and 
phosphorylated  p70s6k),  phosphorylated  mTOR,  S6 
ribosomal protein, and AMP activated kinase (AMPK) 
than  young  (6  mo)  mouse  soleus  (91).  With  under-
production  of  IGF-1  in  aged  skeletal  muscle,  there 
may be impaired mTOR signaling and mRNA trans-
lation, thereby imposing a barrier to protein synthesis 
in aged muscle. 
g. Increased myostatin: Additionally, decreased 
protein synthesis during sarcopenia may be a result of 
elevated myostatin expression in aged skeletal muscle 
(32, 73, 94, 95). There is a two-fold increase in myo-
statin expression within skeletal muscle of aged (70 y) 
subjects relative to young (20 y) subjects (38). GH and 
IGF-1  may  have  an  inhibitory  effect  on  myostatin, 
therefore one potential cause of increased myostatin 
in  aged  skeletal  muscle  is  the  attrition  of  GH  and Int. J. Biol. Sci. 2012, 8 
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IGF-1 expression (38, 73, 95, 96). Myostatin may in-
hibit muscle growth by preventing satellite cell acti-
vation, as well as promoting an adipogenic cell fate 
over myogenicity (95, 97). Inhibiting myostatin may 
be  a  key  therapeutic  target  for  sarcopenia.  Admin-
istration of myostatin inhibitors to aged (18 mo) mice 
resulted in a 12% increase in fiber cross-sectional area 
and 35% increase in force production by the tibialis 
anterior (TA) (94). By understanding the mechanisms 
of the disruption in the pathways for protein degra-
dation  and  protein  synthesis  during  sarcopenia, 
therapeutic interventions can be devised to rejuvenate 
muscle growth and remove damaged muscle proteins 
in aged muscle.  
h.  Altered  microRNA  expression:  MicroRNAs 
(miRNA; miR) are novel post-transcriptional regula-
tors that may contribute to age-related impairments 
by dysregulating gene expression, either by cleaving 
mRNA  or  by  inhibiting  translation  (98-100).  Recent 
evidence suggests that miRNAs play a role in myo-
genesis  (98,  101-107).  During  human  muscle  devel-
opment there is increased expression of muscle spe-
cific miRNAs  including miR-1,-133a, and -206 (103). 
During  postnatal  myogenesis,  these  specific  miRs 
may play a role in skeletal muscle repair by influenc-
ing  myoblast  proliferation  and  differentiation  (98, 
101-108). One week after injecting a mixture of miR-1, 
- 206 and - 133 into injured muscle, there was acceler-
ated muscle repair (104). miR-133a promotes myoblast 
proliferation by repressing factors required for muscle 
differentiation such as serum response factor (SRF), 
myogenin and MHC (107). miR-1 contributes to my-
oblast  differentiation  by  inhibiting  myocyte-specific 
enhancer factor 2C transcriptional repressor, histone 
deacetylast  4  (HDAC4).  miR-206  also  contributes  to 
myoblast differentiation possibly by inhibiting Pax 7 
(101, 106, 107). Inhibiting miR-1 and miR 206 delays 
myoblast  differentiation  and  there  is  a  concomitant 
increase in Pax 3 expression (102).  
Because  it  has  recently  been  determined  that 
miRNA are important to myogenesis, it would be of 
interest to characterize miRNA in aged skeletal mus-
cle. There is a correlation between miRNA expression 
and aging that may link miRNAs to sarcopenia (99, 
109, 110). Drummond et al.  profiled miRNAs in VL 
aged  (~  73  y)  men  relative  to  young  (~  31  y)  male 
subjects and observed that miRNAs let-7b and let-7e 
(from the let-7 family) were elevated in aged muscle 
relative  to  young  muscle.  Let-7  family  miRNAs  are 
related to decreased cell cycle regulators during mus-
cle repair, so the authors suggest that decreased mus-
cle repair mechanisms in aged muscle may be a result 
of elevated Let-7 family miRNA in aged muscle (110). 
The  expression  of  miRNAs  associated  with  skeletal 
muscle repair (miR 221 and -181a) are decreased in 
aged (24 mo) mice quadriceps (109), suggesting that 
these skeletal muscle miRNAs may be associated with 
the decreased muscle growth in aged muscle. More 
research  is  needed  to  determine  the  influence  of 
miRNAs on sarcopenia. 
i. Apoptosis: Apoptosis of myofiber myonuclei 
and satellite cell nuclei within aging skeletal muscle 
may result in muscle mass attrition that is associated 
with  sarcopenia  (33,  111,  112).  Apoptosis  is  a  pro-
grammed death of a cell or nucleus, which is activated 
by either extrinsic or intrinsic cues such as activation 
of death receptors, reactive oxygen species (ROS) ac-
cumulation,  endoplasmic  reticulum  stress  or  mito-
chondrial  stress.  Upon  activation,  components  of 
apoptosis signaling are elevated including caspase 3, 
cytochrome c, BCL-2 associate-X protein (Bax), apop-
tosis-inducing factor (AIF), and/or apoptosis activat-
ing factors (APAF-1) (33, 111, 112). The end result of 
myonucleus or cellular apopotsis is DNA fragmenta-
tion and destruction of the cell, resulting in the for-
mation of apoptotic bodies (33, 111-113). 
Aged skeletal muscle has increased expression of 
pro-apoptotic proteins and caspases and DNA frag-
mentation, with a concomitant decrease in expression 
of anti-apoptotic proteins (112-119). There are eleva-
tions  in  APAF-1,  Bax  levels  and  caspase-3  activity 
(113, 117). Relative to adult (12 mo) rat gastrocnemius, 
aged (26 mo) rat gastrocnemius expressed higher lev-
els of the pro-apoptotic protein AIF, with a concomi-
tant decrease in the apoptotic inhibitor known as the 
apoptotic  repressor  with  a  caspase  recruitment  do-
main (ARC) (120). There are reports of increased an-
ti-apoptotic proteins including XIAP in aged skeletal 
muscle, which are thought to assist in counteracting 
the pro-apoptotic environment within the aged mus-
cle.  However,  the  increased  anti-apoptotic  attempts 
may be futile because there are also elevations in a 
pro-apoptotic  protein  that  inhibits  XIAP 
(Smac/DIABLO)  (33, 121). If apoptosis does indeed 
play a role in sarcopenia, then research directed to-
wards decreasing DNA fragmentation and caspases 
and  promoting  anti-apoptotic  protein  expression  in 
aged skeletal muscle is warranted. 
j. Telomere shortening: With aging there is cel-
lular  senescence  in  multiple  organs.  If  this  process 
occurs in skeletal muscle, then it may contribute to 
sarcopenia (4, 122). The “Hayflick Limit”, defined as 
the  limited  number  of  cell  replications  prior  to  cell 
cycle arrest, may be a cause of cell senescence (123). 
Telomere  instability  may  induce  cellular  arrest  and 
limit  cell  replications  (124).  Telomeres  are  repeated 
DNA sequences that form a T loop cap at the end of a 
linear chromosome and protect the chromosome ends Int. J. Biol. Sci. 2012, 8 
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from  degradation.  Addition  of  DNA  sequences  to 
telomeres  occurs  in  the  presence  of  telomerase  (4). 
With  every  round  of  cell  division  the  telomeres 
shorten  and  telomerase  activity  decreases.  With  in-
creasing age, cells reach the maximum number of cell 
divisions.  At  this  point,  telomere  length  reaches  a 
critical length and the chromosome may become un-
capped.  This  in  turn  may  result  in  disruption  of 
chromosome  integrity  because  uncapped  telomeres 
activate signaling pathways that correlate with DNA 
damage and apoptosis (Figure 1) (124). 
Telomere shortening is used as a marker for ag-
ing, and it is recognized that telomere shortening in-
duces  premature  aging  and  renders  an  organism 
susceptible to disease (122, 125). Mice with deficient 
telomerase  activity  exhibit  shortened  telomeres  and 
have a decreased lifespan (126, 127). There is also a 
relationship between telomere shortening and senes-
cence  of  aged  stem  cells  (128,  129).  Shortened  telo-
meres within hematopoietic stem cells (HSCs) result 
in dysfunctional HSCs and increased HSC senescence 
(128, 129). There is impaired activation and prolifera-
tion  of  HSCs  with  shortened  telomeres  (128,  129). 
Since telomere shortening has been shown to impair 
stem cell function, it is plausible to consider that te-
lomere shortening occurs within cells of aged skeletal 
muscle, including the adult skeletal muscle stem cells 
termed satellite cells. The destructive outcome of te-
lomere shortening in aged skeletal muscle cells may 
contribute to sarcopenia, but more research is needed. 
However, it should be noted that investigators have 
found  that  satellite  cells  from  aged  skeletal  muscle 
maintained  their  telomerase  activity  although  to  a 
lesser degree than those from young skeletal muscle. 
This  suggests  that  aged  skeletal  muscle  stem  cells 
have the ability to maintain their myogenic potential 
(130). 
 
 
 
Figure 1. Telomere function and attrition with aging. 
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k.  Oxidative  Stress:  Accumulation  of  reactive 
oxygen  species  (ROS),  known  as  oxidative  stress 
within aging skeletal muscle contributes to sarcopenia 
(1,  4,  131,  132).  There  are  multiple  sources  of  ROS 
production within aged skeletal muscle (30, 132-134). 
Lifelong  accumulation  of  mitochondrial  DNA 
(mtDNA) mutations in tissues that undergo high ox-
idative phosphorylation such as skeletal muscle, re-
sults  in  decreased  electron  transport  chain  activity, 
impaired  oxidative  phosphorylation  and  ROS  accu-
mulation  (30,  132,  133).  Pro-inflammatory  cytokines 
such as TNFα, which have been shown to be elevated 
in aging skeletal muscle, also promote ROS accumu-
lation (134).  
ROS (as well as reactive nitrogen species) accu-
mulation  within  aged  skeletal  muscle  causes  tissue 
degradation,  skeletal  muscle  atrophy,  decreased 
muscle  function  and  increased  presence  of  fibrotic 
tissue  (1,  4,  30,  131-134).  Oxidative  stress  may  also 
induce DNA damage and impair the ability of DNA 
polymerases  to  copy  strands,  resulting  in  telomere 
shortening (122). The end result of oxidative stress is 
decreased  longevity,  and  this  is  exacerbated  by 
age-associated attrition of antioxidants and heat shock 
protein levels (8, 30, 131). It would seem reasonable 
that  inhibiting  ROS  accumulation  would  increase 
longevity (135). In transgenic mice that over-express 
the antioxidant catalase, there is decreased production 
of ROS and hydrogen peroxide and fewer mitochon-
drial deletions resulting in a 21% increase in lifespan 
relative to control (135). However, many researchers 
report that inhibiting ROS does not prolong lifespan 
(123, 136, 137). Transgenic mice that over-express the 
antioxidant,  superoxide  dismutase  did  not  have  an 
extended lifespan (137). Furthermore, transgenic mice 
that  over-expressed  two  antioxidants;  superoxide 
dismutase and catalase, did not display an extended 
lifespan (136). Because of the age-associated accumu-
lation  of  mtDNA  mutations,  elevated 
pro-inflammatory  levels  and  depressed  antioxidant 
expressions,  there  is  a  robust  presence  of  oxidative 
stress within aged skeletal muscle. The propensity for 
ROS accumulation within aged skeletal muscle may 
induce DNA damage, deplete energy stores and ex-
acerbate apoptosis, thereby contributing to sarecope-
nia (111, 132). Devising methods to decrease ROS ac-
cumulation  within  aged  skeletal  muscle  may  be  a 
promising interventional strategy for sarcopenia. 
There  are  multiple  contributors  to  sarcopenia 
that are associated with DNA damage, apoptosis and 
protein degradation. More research is needed to fur-
ther delineate these molecular manifestations of ag-
ing, and to devise strategies to counteract these dele-
terious  changes.  Another  contributing  factor  to  sar-
copenia is an impaired ability of aged skeletal muscle 
to regenerate following exposure to injury. 
II. Impaired Muscle Regeneration as a Con-
tributor to Sarcopenia 
With aging there is a delay in healing of tissue 
when  exposed  to  injury  as  evidenced  by  poor  skin 
healing, delayed bone repair, inability to re-myelinate 
damaged axons, impaired angiogenesis and delayed 
colonic mucosal repair (138-140). There is also a defi-
cient  regenerative  response  in  aged  skeletal  muscle 
following exposure to injury  (4-8). While there  was 
complete  recovery  of  muscle  mass  at  21  days  post 
chemical-induced muscle injury in 3 mo old rat tibialis 
anterior muscle, there was 40% loss of muscle mass in 
31 mo old rat tibialis anterior muscle at the same time 
point (6). The ability to reinnervate and revascularize 
is reduced in aged muscle compared to young muscle 
(141-143).  There  was  significant  motor  denervation, 
including  loss  of  motor  axon  terminals  in  the  gas-
trocnemius of aged (32 mo) mice (142). Using an in 
situ  blood  vessel  growth  protocol  (corneal  mi-
cropocket assay), Smythe et al. reported that aged (21 
mo)  rat  muscle  exhibited  less  blood  vessel  growth 
than  young  (3  mo)  rat  muscle  (141).  In  addition  to 
poor reinnervation and revascularization, the muscle 
contraction apparatus is affected during recovery of 
aged muscle (144) Lorenzon et al. reported no excita-
tion-contraction (e-c) coupling mechanism present in 
primary  culture  myoblasts  obtained  from  aged  hu-
man  muscle  biopsies,  while  young  primary  culture 
myoblasts demonstrated e-c coupling at day 6 of dif-
ferentiation (144). The delay in skeletal muscle repair 
following injury (chemical-induced, exercise-induced) 
may be a contributing factor to sarcopenia. Below is a 
brief discussion of causes of impaired repair of aged 
skeletal muscle. 
a. Cause of impaired aged skeletal muscle repair 
–  resident  satellite  cell  number:  A  dysregulation  of 
satellite cells could result in impaired repair of aged 
muscle. Muscle regeneration was compared between 
young  (20  y)  and  aged  (70  y)  human  subjects  who 
were  exposed  to  2  wk  muscle  cast  immobilization 
followed by 3 day or 4 week re-loading (cast removal) 
(5). During re-loading there was a ~ four - fold de-
crease in satellite cell activation in aged muscle rela-
tive  to  young  muscle,  suggesting  that  aged  muscle 
may possess dysfunctional satellite cells (5). It is un-
clear if the contributing role of satellite cells to delin-
quent aged muscle regeneration is related to changes 
in resident satellite cell numbers, or to their ability to 
function.  It  is  difficult  to  determine  if  the  overall 
number of satellite cells in aged muscle is a contrib-
uting  factor  to  poor  repair  because  there  is  con-Int. J. Biol. Sci. 2012, 8 
 
http://www.biolsci.org 
739 
founding evidence regarding changes in satellite cell 
number  with  age.  Some  investigators  report  a  de-
crease in satellite cell number with age, while others 
suggest no change or an increase in resident satellite 
cell numbers in aged skeletal muscle (5, 7-9, 32, 73, 
139,  145-149).  Using  Pax  7,  neural  cell  adhesion 
marker (NCAM) and MCadherin satellite cell mark-
ers, Carlson et al. reported a decrease in satellite cell 
number in resting aged (~ 70 y) relative to young (20 
y) human muscle (5). Using a mouse model, Shefer et 
al. showed a 60% decrease in Pax 7 positive-cells of 
aged (19 – 25 mo) relative to young (3 – 6 mo) EDL 
myofibers  (9).  A  plausible  explanation  for  the  per-
ceived decrease of resident satellite cell number with 
age  is  that  satellite  cells  may  have  reached  their 
“Hayflick  limit”  in  which  they  have  reached  the 
maximum threshold of cell divisions. Although there 
is a preponderance of evidence supporting the con-
cept of decreased satellite cell number with aging, it 
should be noted, however, that there are reports stat-
ing no differences in satellite cell number with age (11, 
150). Using electron microscopy, dystrophin-laminin 
immunohistochemistry,  and  MyoD  immunohisto-
chemistry  techniques  for  quantifying  satellite  cells, 
Brooks  et al.  did  not  observe  any  significant  differ-
ences in satellite cell numbers between young (5 mo) 
and aged (24 mo) Fisher rat soleus muscles (150).  
b. Cause of impaired aged skeletal muscle repair 
– altered myogenic program: Independent of the con-
tribution  of  resident  satellite  cell  number,  it  is  well 
known that there is a problem with satellite cell func-
tion in the myogenic program of aged muscle (7, 9-11, 
151). However, exactly what aspect of the myogenic 
program is defective in aged muscle remains contro-
versial. Some investigators state that myoblast prolif-
eration is the limiting factor for effective age muscle 
repair,  while  others  suggest  that  the  impairment  is 
due to diminished myotube formation (7, 9-11, 13, 30, 
151, 152). Shefer et al. reported a reduced proliferation 
in aged myoblasts because there was only a 10 fold 
increase in proliferation of myogenic cells from cul-
tured aged (28 – 33 mo) mouse myofibers (at 6th day of 
plating relative to 4th day of plating), while myoblast 
proliferation  of  young  mouse  (3  –  4  mo)  myofiber 
cultures increased 15 fold at the same time point. Ad-
ditionally,  there  was  a  24  h  delay  in  myotube  for-
mation in the aged group, but no morphological dif-
ferences  in  myotube  formation  between  the  young 
and  aged  groups  were  observed  (9).  Similarly, 
Conboy et al. reported fewer proliferating myoblasts 
and myotubes from myofiber explants of aged (23 – 24 
mo)  relative  to  young  (2  -3  mo)  mouse  muscle  (7). 
These authors suggest that aged satellite cells retain 
their myogenic potential but have an impaired ability 
to activate and proliferate resulting in a delay of my-
otube formation (7, 9). 
However, there is evidence that the differentia-
tion component of the myogenic program is defective 
in  aged  muscle  (10,  11,  13,  30,  151,  153).  Although 
there was no significant difference in the percentage 
of desmin-positive cells between myoblasts obtained 
from young (~ 30y) and aged (~83y) human myofiber 
explants, there was a significant decrease in the fusion 
index of aged myotubes relative to young myotubes 
(11).  The  authors  also  reported  that  the  aged  myo-
tubes  had  fewer  myonuclei  than  young  myotubes, 
and  that  the  aged  myotubes  morphology  appeared 
meager (11). Lees et al. reported that although there 
was no difference in the profile of proliferating pro-
teins from cultured myogenic precursor cells (mpcs) 
between young (3 mo) and aged (32 mo) rat muscle, 
the aged mpcs expressed 50% less of the differentia-
tion proteins myogenin and creatine kinase relative to 
young mpcs. In addition, there was less expression of 
p27kip1, and FOXO1 (proteins essential for  myoblast 
differentiation)  in  the  aged  relative  to  young  mpcs 
(151). 
Altered expression of myogenic regulatory fac-
tors (MRFs) and myostatin may play a role in inhib-
iting proliferation or differentiation in aged regener-
ating muscle. Expression of MyoD, myf5, myogenin 
and MHC are decreased in aged muscle (30, 73). In 
addition, there may be decreased protein turnover in 
aged  muscle  resulting  in  impaired  myosin  replace-
ment (30). Furthermore, the presence of free radicals 
in aged muscle renders the myosin molecule suscep-
tible to oxidation and weakens cross bridge formation 
(30,  154).  There  is  also  decreased  expression  of 
E-proteins, which are critical co-regulators of MRFS, 
but increased expression of Id, an inhibitor of differ-
entiation (30, 155). Id promotes apopotosis and mus-
cle  atrophy  by  inhibiting  E-protein/MRF  dimeriza-
tion or by preventing MRFS binding to DNA (which 
prevents muscle growth) (155-157). 
As previously discussed, the muscle growth in-
hibitor myostatin may contribute to impaired muscle 
repair (32, 73, 158, 159). Administration of recombi-
nant myostatin to C2C12 cells (a skeletal muscle cell 
line) inhibited myoblast differentiation and decreased 
expression of MyoD, myf5, myogenin and p21 (159). 
The  authors  suggested  that  myostatin  may  inhibit 
MyoD through increased Smad 3 signaling (a media-
tor of myostatin signaling that inhibits myogenesis). 
MyoD expression was recovered when Smad 3 mol-
ecule was inhibited (through the expression of domi-
nant-negative Smad 3 in C2C12 cells) (159). There may 
be a positive-feedback mechanism in which myostatin 
may inhibit MRF expression, and  the loss of MyoD Int. J. Biol. Sci. 2012, 8 
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and  myogenin  may  further  up-regulate  myostatin 
expression (73, 159). 
While  there  preponderance  of  evidence  shows 
decreased MRF and elevated myostatin in aged skel-
etal muscle, it should be acknowledged that there are 
reports stating either no change in MRF or myostatin 
expression, or elevations of MRF expression in aged 
muscle  (6,  142,  160-162).  Myogenin  protein  levels 
were ~ 5.5-fold higher in gastrconemius of aged (32 
mo) rats relative to young (4 mo) rats (142). Aged (31 
mo)  rats  exposed  to  chemical  injury  displayed  ele-
vated myogenin mRNA levels at 21 days post-injury, 
while  myogenin  mRNA  returned  to  normal  at  that 
time point in 3 mo old rats (6). Myostatin expression 
in mouse gastrocnemius and plantaris increased from 
birth  until  11  wks  of  age  (161).  Although  there  are 
studies that suggest aging does not negatively affect 
myogenic protein and myostatin expression, the au-
thors’ support the notion of decreased MRF in aged 
skeletal muscle that affect muscle repair. The plethora 
of  evidence  offer  viable  mechanisms  for  impaired 
MRF expression which occur in aging tissue such as 
decreased  protein  synthesis,  increased  oxidative 
stress, as well as evidence of increased MRF inhibitor, 
myostatin.  
c. Cause of impaired aged skeletal muscle repair 
–  intrinsic  factors:  The  intrinsic  alterations  within 
satellite cells that occur during aging negatively affect 
satellite cell integrity. With aging, satellite cells may 
have reached their “Hayflick limit” and reached their 
cell  division  threshold,  which  would  result  in  de-
creased satellite number and ultimately impaired re-
generation (8). In addition, there is increased apopto-
sis in aged satellite cells and myonuclei, which further 
depletes the satellite cell pool as judged by differences 
between aged (31 mo) and young (3 mo) rat EDL sat-
ellite  cells  (33,  163).  Cultured  aged  myofibers  with 
depleted  Pax7+  satellite  cells  became  apoptotic  re-
sulting in few differentiated myotubes (164). 
Cell  size  regulation  is  another  intrinsic  factor 
that may impact satellite cells (165). Brack et al. sug-
gest that nuclear domain size is maintained with age 
because the age-associated loss of myonuclei, includ-
ing loss of satellite cells, causes the cytoplasm to di-
minish  and  the  size  of  the  muscle  fiber  decreases. 
Whether  the  loss  of  myofiber  nuclei  causes  muscle 
atrophy, or if muscle atrophy causes the loss of my-
onuclei is controversial. Brack et al. suggest that im-
paired satellite cell function or quantity may contrib-
ute to the age-associated loss of myonuclei. Although 
there is controversy about the ability of aged muscle 
to regulate nuclear domain size, Brack et al. propose 
that effective satellite cell function may be critical for 
maintaining nuclear domain and cell size control, and 
that  impaired  satellite  cell  function  in  aged  muscle 
may  contribute  to  the  loss  of  myonuclei  and 
age-associated muscle atrophy (165). 
Another  intrinsic  factor  that  contributes  to  ag-
ing-associated impaired satellite cell function is alter-
ation  of  RNA  pathways,  including  dysfunctional 
pre-RNA  processing  within  satellite  cell  nuclei  that 
impacts gene expression (166). In addition, there are 
alterations  of  ribonucleopreotein  (RNP)-containing 
structures within aged muscle (166, 167). In aged rat 
satellite  cell  nuclei,  there  was  accumulation  of 
rnRNPS (involved with pre-mRNA splicing), which 
signified  dysfunctional  intranuclear  transport  of 
transcripts (166). Malatesta et al. also found decreased 
pre-mRNA transcription rate and decreased nucleo-
plasmic splicing factors in myonuclei of aged myofi-
bers (167). The authors suggest that mRNA processing 
is less efficient in aged than young muscle, and that 
impaired mRNA function may contribute to the im-
paired satellite cell activity reported in aged muscle 
(166).  
Cell fate choice is another intrinsic factor influ-
encing  aged  satellite  cell  function  (14,  149).  The  in-
creased presence of adipose tissue (such as adipocyte 
differentiation marker C/EBP) in aged muscle sug-
gests that satellite cells may prefer an altered cell fate. 
Instead of choosing myogenic cells, the satellite cells 
commit to non-myogenic cell fates including adipo-
genic or fibrogenic cells (149). There was greater ex-
pression of adipogenic genes (fatty acid binding pro-
tein  aP2)  in  myoblasts  cultured  from  aged  (23  mo) 
relative  to  young  (8  mo)  mouse  hindlimb  muscles 
(168).  The  change  in  cell  fate  decision  away  from 
myogenesis in aged skeletal muscle may be associated 
with decreased myogenic capacity and increased ad-
ipogenesis (168). Aged satellite cells may also choose 
fibrogenesis over myogenic cell fate (14). Aged myo-
fiber  explant  cultures  had  increased  fibronectin  ex-
pression  relative  to  young  myofiber  explants 
cultures(14).  A  satellite  cell’s  preference  for  adipo-
genic  or  fibrogenic  cell  fate  would  result  in  an  im-
pairment in the regenerative potential of aged skeletal 
muscle. 
d. Cause of impaired aged skeletal muscle repair 
–  microenvironment  mileu:  Another  reason  for  the 
delay  in  the  aged  myogenic  program  may  be  the 
composition of the environmental mileu surrounding 
the  satellite  cells  (9,  13,  139,  145,  169-172).  Young 
muscle transplantation into aged tissue milieu results 
in myogenic delay (141, 170, 172). In addition, there is 
decreased satellite cell proliferation and expression of 
myoblast markers desmin and myf5 in satellite cells 
exposed to serum from aged muscle  (170). Further-
more, when young (2 mo) or aged (15 – 21 mo) mouse Int. J. Biol. Sci. 2012, 8 
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EDL  muscle  was  transplanted  into  an  aged  host 
mouse,  there  was  a  delay  in  the  inflammatory  re-
sponse and myoblast differentiation (141). These re-
sults  suggest  that  the  microenvironment  of  aged 
skeletal  muscle  suppresses  myogenic  capability. 
However, positioning aged skeletal muscle in a young 
muscle  tissue  environmental  milieu  accelerates  its 
repair  (9,  13,  139,  145,  169,  170,  172,  173).  Hetero-
chronic  transplantation  studies  and  parabiotically 
paired  mice  demonstrate  that  in  the  presence  of 
young  environment,  both  aged  and  young  satellite 
cells are able to fully activate and the muscle is com-
pletely repaired (13, 173, 174). EDL muscle of aged (32 
mo) rats that were transplanted into young (4 mo) rat 
muscle  achieved  regenerative  capacity  and  force 
production on par with that of young to young mus-
cle transplantation. This finding suggests that extrin-
sic factors within the muscle microenvironment may 
govern a muscle’s capacity for regeneration (169). In 
addition, there is decreased collagen replacement of 
aged muscle fibers during young and aged parabosis 
experiments,  suggesting  that  factor(s)  within  the 
young circulation prevent non-myogenic cell fate, and 
also that factor(s) in aged circulation promotes fibrosis 
and loss of myogenesis (14). These data suggest that 
both  young  and  aged  satellite  cells  have  myogenic 
potential, and that it is the tissue environment that 
may govern the success of myogenic repair.  
Determining  the  difference  in  composition  be-
tween the young and aged muscle environment may 
result in the identification of factors present in each 
respective milieu that promote or inhibit myogenesis. 
Satellite cells are physically located next to the myo-
fiber (sarcolemma, basal lamina) and are also adjacent 
to capillaries, rendering them susceptible to exposure 
to  cells  from  the  systemic  environment  (interstitial 
cells, endothelial cells, inflammatory cells, adipocytes, 
fibroblasts)  (171,  175,  176).  Neighboring  cells  may 
physically interact with satellite cells to influence sat-
ellite  cell  function,  and  any  disruption  in  the  rela-
tionship could impact the ability of the satellite cells to 
activate  (145,  171,  176-182)Satellite  cells  physically 
connect  with  laminin,  a  major  protein  of  the  basal 
lamina,  which  accelerates  myoblast  movement  and 
proliferation  (177).  The  cooperation  of  satellite  cells 
and endothelial cells is also critical for muscle growth 
(171, 175, 179, 181). There is increased myoblast pro-
liferation  in  co-culture  experiments  using  isolated 
human  myogenic  cells  and  human  microvascular 
endothelial cells compared to controls (myogenic cells 
co-cultured with other myogenic cells or fibroblasts) 
(179).  Inflammatory  cells  such  as  macrophages  also 
interact with myoblasts to promote proliferation and 
inhibit  apoptosis  as  demonstrated  by  co-culture  ex-
periments  (179-181).  Furthermore,  myoblasts  and 
connective tissue may interact to facilitate muscle re-
pair  (178,  182).  Muscle-connective  tissue  fibroblasts 
(tcf4+)  are  physically  situated  near  Pax  7+  satellite 
cells and regenerating myofibers (embryonic MHC+). 
Murphy  et  al.  found  a  concomitant  increase  in  ex-
pression  of  tcf4+,  Pax  7+  and  embryonic  myosin 
heavy chain (eMHC +) cells following muscle injury. 
When  Pax 7+  - cells  were ablated there was a 52% 
decrease in tcf4+ fibroblast expression, and following 
the ablation of tcf4+ cells, there was a 51% decrease in 
Pax  7+-  satellite  cell  expression  and  impaired  my-
oblast proliferation. This relationship between satel-
lite  cells  and  tcf4+-  muscle  connective  tissue  fibro-
blasts  suggests  that  these  cells  communicate  to  or-
chestrate muscle repair (178).  
Although  not  well  known,  one  potential  con-
tributing  factor  to  impaired  muscle  regeneration  in 
aged skeletal muscle is a dysfunction in the interac-
tion  of  satellite  cells  with  neighboring  cells. 
Age-associated  accumulation  of  damaged  proteins 
may  affect  the  physical  interaction  of  aged  satellite 
cells  with  their  neighboring  cells  (145).  In  addition, 
there  are  dysfunctional  monocytes  and  decreased 
phagocytosis in aged skeletal muscle (172, 174). Be-
cause the relationship between macrophages and sat-
ellite cells is important for muscle repair, the impaired 
phagocytic  activity  in  injured  aged  skeletal  muscle 
could  be  one  cause  of  poor  muscle  repair  in  aged 
skeletal muscle. Also, age-associated nerve denerva-
tion and decreased blood supply, including impaired 
neo-vascularization within the aged skeletal muscle, 
may result in reduced physical contact between satel-
lite cells and nerves or endothelial cells in aged skel-
etal muscle which may negatively impact muscle re-
pair  (172,  183).  Little  is  known  about  the  physical 
connections  between  aged  satellite  cells  and  neigh-
boring cells, but because it is apparent that the inter-
actions of neighboring cells and satellite cells are crit-
ical for muscle repair, it would appear logical that a 
contributing factor to impaired regeneration of aged 
skeletal  muscle  could  be  the  altered  relationships 
between  aged  satellite  cells  and  neighboring  cells 
(145). 
In  addition  to  the  physical  interaction  with 
neighboring  cells,  satellite  cells  are  exposed  to  re-
leased  factors  that  could  have  positive  or  negative 
influences on satellite cell integrity, depending on the 
age of the microenvironment (145, 176, 181, 184-187). 
The literature is robust in describing the sources of 
growth factors within the satellite cell niche, and their 
importance for postnatal myogenesis in young skele-
tal muscle (175, 178, 181, 184). However, within the 
aged muscle microenvironment, there is an increased Int. J. Biol. Sci. 2012, 8 
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presence of inhibitory factors that may contribute to 
impaired  regenerative  capability  (13,  145,  173,  181, 
185, 188). As discussed in the previous sections of this 
review, in aged organisms there is a decline in sys-
temic factors such as IGF-1, which are known to be 
important for postnatal myogenesis (188, 189). Aged 
transgenic  mice  with  over-expressed  IGF-1  did  not 
demonstrate the classic muscle atrophy signs typically 
associated with aged wild type mice suggesting that 
IGF-1 may protect against sarcopenia (88, 188). There 
is also attrition of other skeletal muscle repair growth 
factors including Vascular Endothelial Growth Factor 
(VEGF)  within  aged  skeletal  muscle.  Aged  (22  mo) 
mouse  myofibers  expressed  less  VEGF  relative  to 
young (2.5 mo) controls (181, 187). In addition, there is 
increased  endothelial  cell  apoptosis  in  aged  tissue, 
which may result in a reduction in the secretion of 
endothelial-derived factors that activate satellite cells 
(179,  187,  190).  Because  endothelial  cells  and  their 
secreted VEGF are critical for myogenic regulation, it 
is plausible to suggest that fewer endothelial cells, and 
decreased  VEGF  expression,  may  contribute  to 
aged-associated impairment of muscle regeneration. 
While  some  growth  factors  are  suppressed  in 
aged skeletal muscle, other growth factors within the 
satellite cell niche are elevated, and these growth fac-
tors,  including  transforming  growth  factor  (TGF)   
and 1 function to inhibit muscle repair (5, 12, 181). 
Relative to young (20 yr) human vastus lateralis myo-
fibers, aged (70 yr) human myofibers showed greater 
expression  of  TGF/pSmad  and  subsequent  de-
creased myogenic proliferation (5). Administration of 
TGF  to  aged  human  satellite  cells  resulted  in  de-
creased expression of desmin and MyoD in prolifer-
ating  myoblasts,  which  suggests  that  TGF  inhibits 
muscle  repair  (5).  TGF  increases  the  expression  of 
cyclin-dependent  kinase  (CDK)  inhibitors  and  pre-
vents  cMyc  expression,  which  results  in  attenuated 
myogenic proliferation (5, 12).  
Depressed  levels  of  steroid  hormones  in  aged 
skeletal  muscle  may  indirectly  elevate 
pro-inflammatory cytokines IL-6 and TNFα levels in 
the satellite cell niche (8, 53, 54, 191). IL-6 has con-
flicting roles during muscle repair because it is known 
to be essential for satellite cell activation  (192), but, 
when acting as a pro-inflammatory cytokine, IL-6 is 
also known to be associated with decreased satellite 
cell number and a loss of proliferative capacity (8). As 
described above, TNFα expression levels increase in 
aged muscle and TNFα has antagonist effects on aged 
muscle regeneration (29, 30, 38, 45, 193). Transgenic 
mice  over-expressing  TNFα  in  muscle  tissue  show 
impaired satellite cell proliferation and differentiation 
following reloading of atrophic  muscle  (193).  TNFα 
suppresses  MRFs  and  myoblast  differentiation,  re-
sulting in impaired muscle repair processes (29, 30). 
Based  on  the  evidence  of  the  deleterious  effects  of 
elevated IL-6 and TNFα on aged skeletal muscle re-
pair,  it  is  interesting  to  speculate  that  developing 
therapeutic  tools  that  target  increased 
pro-inflammatory mediators may assist in combating 
sarcopenia.  It  is  well  identified  that  the  host  envi-
ronment plays an essential role in the success of my-
ogenic processes, and that this microniche is altered in 
aged  skeletal  muscle,  thereby  negatively  impacting 
myogenic potential. 
There are many potential mechanisms that may 
account  for,  or  contribute  to,  the  impaired  muscle 
repair  that  is  associated  with  aged  skeletal  muscle 
including alterations in extrinsic or intrinsic factors. 
The effect of aging on signaling pathways known to 
be critical for muscle repair also need to be considered 
as a contributing factor to impaired muscle repair and 
sarcopenia. 
III. The Role of Notch and Wnt on Impaired 
Muscle Repair in Aged Muscle 
Understanding the differences in cell signaling 
pathways  between young  and aged skeletal  muscle 
may help identify mechanisms underlying impaired 
cellular regeneration in aged skeletal muscle. Notch 
and  Wnt  signaling  are  known  to  be  important  for 
muscle repair and appear to be dysfunctional in aged 
muscle (7, 12, 13, 194).  
a.  Notch  signaling  in  aged  skeletal  muscle  re-
pair: The literature is robust in discussion of Notch 
signaling and its importance to myogenesis (23, 195). 
In  summary,  Delta  ligand  interacts  with  full  length 
Notch receptor which is cleaved, and translocated to 
the nucleus where it up-regulates transcription factors 
(Hes1,  Hey1)  resulting  in  myoblast  proliferation. 
Notch  signaling  is  impaired  in  regenerating  aged 
skeletal muscle (7, 12, 13, 195). There is less Notch1 
receptor and Delta1 ligand present in aged activated 
satellite cells than in young activated satellite cells (7, 
12). Insufficient activation of Notch contributes to the 
diminished regenerative capacity of aged muscle (7, 
13). In satellite cells isolated from aged mouse skeletal 
muscle,  decreased  Delta  ligand  expression  on  acti-
vated aged satellite cells corresponded with less my-
oblast proliferation compared to young satellite cells 
(7).  Force-activating  Notch  in  injured  aged  muscle 
increased satellite cell activation and myoblast prolif-
eration (7). 
b. Influence of circulating factors on Notch sig-
naling: Using the parabiotic model, Conboy et al. de-
termined that Delta ligand expression can be rescued 
in aged skeletal muscle (13). In parabiotically paired Int. J. Biol. Sci. 2012, 8 
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young  and  aged  mice,  the  circulatory  systems  be-
tween the animals are shared. Consequently, the sat-
ellite cells of the aged mouse muscle are exposed to 
factors  circulating  within  the  young  mouse.  This 
pairing model permits the investigation of the effect 
of serum from young mice on the repair of aged skel-
etal muscle. The extent of aged skeletal muscle repair 
when aged mice are paired with young mice is com-
pared to that observed in aged mice when two aged 
mice are parabiotically paired. When young and aged 
mice are paired and the TA of the aged mouse muscle 
is injured, there is an approximate 5-fold increase in 
Delta  ligand  expression  in  activated  satellite  cells 
from the injured aged mouse relative to aged-to-aged 
mouse pairing. In addition, the young-aged pairing 
restored  aged  muscle  regeneration  capability  (13). 
These  data  suggest  that  extrinsic  factors  within  the 
young serum may rescue the Notch signaling deficit, 
and contribute to the reversal of the poor regenerative 
capacity in aged muscle (13). In addition, there was 
decreased  muscle  regenerative  capacity  in  injured 
young mouse muscle that was paired with aged mice, 
suggesting the presence of muscle regenerative inhib-
itors in aged serum (7, 12). 
c. Impairment of upstream factors that activate 
Notch  signaling:  The  decreased  Notch  signaling  in 
aged  muscle  may  be  associated  with  impaired  ex-
pression of upstream factors that activate Notch sig-
naling (5, 194). One potential Notch activator is the 
mitogein-activated  protein  kinase 
(MAPK)/phosphate  extracellular  signal-regulated 
kinase (pERK) pathway. MAPK/pERK is depressed 
in aged muscle (5). Aged (~ 70 y) human VL muscle 
exposed  to  cast  immobilization  followed  by  reload-
ing-induced  muscle  injury  expresses  less 
MAPK/pERK than young (~ 20 y) muscle exposed to 
reloading of atrophic muscle (5). Carlson et al. showed 
that  aged  satellite  cells  treated  with  MAPK  agonist 
increases Notch signaling (5). Developing a tactic to 
activate  MAPK/pERK  signaling  in  aged  skeletal 
muscle may increase Notch signaling and rejuvenate 
impaired aged skeletal muscle repair. 
The sex hormone, testosterone is known to in-
crease Notch signaling. Because testosterone levels are 
depressed in aged skeletal muscle, one potential cause 
for impaired Notch signaling in aged skeletal muscle 
may be a reduction in testosterone levels (57). Young 
(7 – 8 wks) mice had endogenous testosterone levels 
depleted and were then administered a testosterone 
implant, which resulted in increased Notch 1, Notch 2 
and Delta 1 expression (196). Application of a testos-
terone implant to aged (22mo) mice, also resulted in 
Notch 1 receptor expression in aged skeletal muscle 
(60). Thus, testosterone is a potential candidate that 
up-regulates Notch signaling and may be considered 
as  a  potential  therapeutic  treatment  option  for  im-
paired aged skeletal muscle repair. 
d.  Increased  Notch  signaling  inhibitors:  Im-
paired Notch signaling in aged skeletal muscle may 
also  be  related  to  increased  levels  of  inhibitors  of 
Notch within the myogenic mileu (194, 195). As dis-
cussed in the preceding sections, aged skeletal muscle 
has  increased  levels  of  TNF,  which  is  thought  to 
contribute to sarcopenia and impair myogenesis, pos-
sibly by inhibiting Notch signaling (197). There was 
decreased mRNA and protein expression of Notch 1 
receptor  in  mononuclear  cells  isolated  from  mdx 
mouse  muscle  that  was  treated  with  TNF  (197). 
TGF  may  be  another  inhibitor  of  Notch  signaling, 
and a source of reduced regenerative capacity in aged 
skeletal muscle (5). Aged (~ 71 y) human VL skeletal 
muscle expresses more TGF protein than young (~ 
23 y) subjects, and when TGF was administered to 
satellite cells isolated from aged (~ 71 y) human skel-
etal muscle, there was decreased myogenic potential 
relative to young (~ 23 y) isolated human satellite cells 
(5). Research reports an imbalance between TGF and 
Notch signaling in human and rodent skeletal muscle 
models  in  which  elevated  TGF  levels  negatively 
correlate  with  decreased  Notch  signaling  in  aged 
skeletal muscle (5, 12, 195). In addition, forced activa-
tion of Notch inhibits TGFβ-induced up-regulation of 
CDK inhibitors in satellite cells (12). These two sig-
naling pathways may be integrated during postnatal 
myogeneisis.  Research  is  needed  to  delineate  the 
mechanisms underlying the observation that an im-
balance  of  TGF  and  Notch  impairs  aged  skeletal 
muscle regeneration. In addition, inhibitors of Notch 
signaling  that  are  present  within  the  aged  skeletal 
muscle mileu need be identified. 
e. Wnt signaling and aged muscle repair: In ad-
dition to alterations in Notch signaling, Wnt signaling 
may contribute to impaired aged skeletal muscle re-
pair. Activation of canonical Wnt/β-catenin signaling 
follows  when  soluble  Wnt  ligands  interact  with  re-
ceptors such as Frizzled and low-density lipoproteins. 
Upon  Wnt  activation,  GSK3’s  phosphorylation  of 
-catenin is inhibited, which allows nuclear translo-
cation  of  -catenin.  Within  the  nucleus,  activated 
-catenin binds to transcription factors such as T-cell 
factor-1  (TCF1)  and  lymphoid-enhancing  factors  -1 
(LEF1),  resulting  in  skeletal  muscle  repair  (23,  198, 
199). 
The  role  of  Wnt  signaling  in  impaired  aged 
skeletal muscle repair is controversial. Some suggest 
that there is an exacerbation of Wnt signaling in aged 
skeletal muscle. Although Wnt signaling is required Int. J. Biol. Sci. 2012, 8 
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for completion of muscle repair, the incongruous el-
evation of Wnt signaling in aged skeletal muscle may 
result  in  dysfunctional  myogenic  capability  and  ac-
celeration of aging (14-17). Liu et al. used the klotho 
mouse model (klotho deficient mice have accelerated 
aging) and observed increased Wnt signaling that was 
associated with the observed cell senescence and de-
creased life span (200). There was increased Wnt sig-
naling in mesenchymal stem cells that were incubated 
with aged (64 – 68 wks) rat serum (17). In the presence 
of Wnt inhibitors, Dickoppf (DKK1) or siRNA against 
β catenin, there is a reversal of the proliferation inhi-
bition (17). Decreased GSK3 and increased -catenin 
and Axin 2 (a downstream target of Wnt signaling) 
expression was observed in aged satellite cells relative 
to young satellite cells (14). In addition, Brack et al. 
also  reported  increased  β-galactosidase  activity  in 
aged  TOPGAL  mice  (which  express  the 
β-galactosidase reporter gene under the control of a 
promoter responsive to β-catenin) compared to young 
TOPGAL mice (14, 201). Scime et al. found decreased 
levels  of  Wnt  antagonists  (Secreted  frizzled-related 
protein 2 [Sfrp2] and Wnt inhibitor factor 1 [Wif1]) in 
aged mouse skeletal muscle relative to young mouse 
muscle, suggesting increased Wnt activity with aging 
(15). The presence of Wnt signaling in the circulation 
was compared in young and aged serum (14). Brack et 
al. performed parabiotic experiments between young 
and aged mice and demonstrated that there was de-
creased Wnt signaling (increased GSK3 expression) 
in aged myogenic cells when exposed to young mouse 
serum,  and  increased  Wnt  signaling  (decreased 
GSK3  expression)  in  young  myogenic  cells  when 
paired  with  aged  mice.  In  addition,  using  a  fusion 
protein of Wnt receptor, Frizzled, (Frizzled-Fc), Brack 
et  al.  indirectly  measured  increased  levels  of  Wnt 
signaling  components  in  aged  circulation.  When 
Frizzled-Fc  was  incubated  with  serum  from  aged 
mice,  there  was  decreased  Wnt  activity,  however 
young serum incubated with Frizzled-Fc did not in-
duce  a  change  in  the  degree  of  Wnt  signaling  (14). 
These data suggests that there is an up-regulation of 
Wnt signaling components in aged systemic circula-
tion  relative  to  young  circulation,  and  that 
up-regulation of Wnt signaling may promote aging.  
Increased Wnt signaling in aged skeletal muscle 
may inhibit myogenicity (14). Brack et al. reported that 
relative  to  satellite  cells  isolated  from  young  mice, 
satellite  cells  isolated  from  aged  (24  –  26  mo)  mice 
expressed less myogenic marker Pax 7. Brack et al. also 
reported that satellite cells isolated from aged (24 – 26 
mo)  mice  treated  with  the  canonical  Wnt  inhibitor, 
Sfrp3,  resulted  in  an  increased  number  of  des-
min+/BrdU+  cells  and  rejuvenation  of  myogenicity 
(14). These data suggest that inappropriate increases 
in  Wnt  signaling  within  aged  skeletal  muscle  may 
impair  myogenic  capability.  It  is  plausible  that  un-
timely  elevation  of  Wnt  in  the  circulation  may  be 
considered a myogenic inhibitor in the aged muscle 
micro-environment  
Wnt may also contribute to impaired muscle re-
generative potential by promoting the age-associated 
transition of aged skeletal muscle to fibrogenic tissue, 
thereby accelerating aging (14, 26, 34, 200, 202-204). 
Wnt  signaling  is  known  to  promote  fibrosis  in  pa-
thologies such as pulmonary and renal fibrosis, cir-
rhosis  and  colorectal  carcinoma  (205-209).  There  is 
increased active ß-catenin expression in hepatocytes 
of cirrhosis patients, as well as within the fibroblasts 
of  proliferating  bronchiole  lesions  in  patients  with 
pulmonary fibrosis (206, 207). Injections of Wnt4 into 
renal  capsule  of  mice  produced  fibroblastic  lesions, 
while administration of Wnt inhibitor, sFRP4 resulted 
in  decreased  renal  fibrosis  formation  (208,  209).  In 
regards to aged skeletal muscle, Brack et al. injected 
soluble Wnt3a into young muscle and  observed in-
creased  Gomori  stain  (a  connective  tissue  marker). 
Brack et al. also reported a greater propensity for aged 
satellite cells to differentiate into fibroblasts than sat-
ellite cells isolated from young mice (14). When young 
(6  wk)  mdx  mice  were  injected  with  Wnt  inhibitor 
DKK1, there was a decrease in fibrosis (203). These 
data provide evidence that a potential mechanism by 
which Wnt signaling may impair aged skeletal muscle 
regeneration is the promotion of fibrogenesis in aged 
skeletal muscle. 
A  shift  in  the  equilibrium  between  Notch  and 
Wnt signaling may be another contributor to impaired 
regeneration of aged skeletal muscle. Wnt signaling 
orchestrates with Notch during post-natal myogenesis 
for  complete  muscle  repair  (23,  210,  211).  During 
post-natal myogenesis, Notch signaling is critical for 
satellite cell activation and myoblast proliferation. At 
this point, Notch is down-regulated and Wnt signal-
ing completes the muscle repair process by advancing 
myoblast differentiation and fusion to ultimately form 
myofibers  (23,  210,  211).  A  suggested  imbalance  of 
these signaling pathways during aged skeletal muscle 
repair may occur as a result of an attenuation of Notch 
signaling and exacerbation of Wnt signaling resulting 
in dysfunctional repair of aged skeletal muscle (12-14, 
195, 200, 202, 204). There is evidence for Wnt’s nega-
tive influence on aging skeletal muscle repair, which 
supports the need for further investigations to ascer-
tain Wnt’s role in impaired aged muscle repair and 
sarcopenia. 
Evidence suggesting that Wnt signaling does not 
accelerate aging, or play  a critical role in inhibiting Int. J. Biol. Sci. 2012, 8 
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muscle repair in aged muscle should be recognized 
(185, 202). Carlson et al. did not find any differences in 
Wnt3a  expression  in  serum  from  aged  humans  or 
mice relative to young human or mouse serum. These 
authors  also  did  not  observe  rejuvenation  of  myo-
genic proliferation (desmin+/BrdU+) in aged myofi-
bers explants that were incubated with aged serum 
treated with Wnt inhibitor, Sfrp3. Furthermore, these 
authors suggest that Wnt activity may be greater in 
young muscle because there is less active GSK3β in 
young satellite cells treated with young serum com-
pared to aged satellite cells treated with aged serum 
(185). Research suggests that Wnt signaling may im-
pede the aging process (202, 212, 213). Inhibition of 
GSK-3ß and activation of Wnt signaling may delay the 
onset  of  age-related  diseases  such  as  Alzheimer’s 
Disease (202, 212, 213). Ye et al.  showed  an inverse 
correlation between cell senescence and Wnt signaling 
in  aged  human  cells  in  which  there  was  decreased 
expression  of  Wnt  signaling  components  (elevated 
GSK-3ß and decreased ß-catenin activities) in cultured 
human  fibroblasts  that  underwent  58  population 
doublings and were characterized as senescent (213).  
Although  there  are  studies  that  suggest  Wnt 
signaling does not influence aging, the review of lit-
erature reports compelling evidence that Wnt signal-
ing contributes to aging. The reports of increased Wnt 
signaling  in  the  mouse  model  of  accelerated  aging 
(Klotho)  (200),  presence  of  Wnt  induced-fibrosis  in 
aged skeletal muscle (14) and increased Wnt signaling 
in aged TOPGAL mice (14, 201) provide confirms the 
concept that elevated Wnt contributes to aging and 
may affect repair of aged muscle. The inconsistencies 
in the results of studies designed to explore the role of 
Wnt in impaired aged skeletal muscle repair may be 
related to the models utilized to study the effect of 
Wnt signaling on aged skeletal muscle repair. Alter-
natively, the differences may be associated with the 
pleitropic roles of Wnt, which depend on a variety of 
signals. More work is needed is ascertain Wnt’s con-
tribution to impaired aged skeletal muscle repair. For 
example,  therapeutic  modalities  (such  as  exercise) 
that take advantage of the benefits of circulatory fac-
tors that promote the proper orchestration of Notch 
and Wnt signaling and rejuvenation of impaired aged 
skeletal muscle repair need to be explored. 
IV. The Effect of Physiological Stimuli on the 
Molecular and Cellular Manifestations of Sar-
copenia 
To obtain a more complete understanding of the 
factors that may underlie the pathological manifesta-
tions  of  sarcopenia  (Table  1),  studies  exploring  the 
responses  of  aged  skeletal  muscle  to  physiological 
stress  (such  as  exercise)  should  be  included.  Im-
portant information regarding the deleterious effects 
of aging on skeletal muscle can be obtained by per-
forming experiments in which the muscle is exposed 
to  an  acute  bout  of  physiological  stimuli.  Further-
more, an examination of the adaptive mechanisms of 
aged skeletal muscle that is exposed to repeated bouts 
of physiological stimuli (exercise training) may assist 
in determining potential counter measures to sarco-
penia. 
 
Table 1. Strength of evidence for factor contribution to sarcopenia. 
Factor suggested to contribute to sarcopenia  Extent of evidence   References 
 Intramuscular fibrosis and adipose tissue  Strong  14,25,26,28,34 
 TNF and IL-6  Strong  35-42,44,45 
 Sex hormone   Strong  1,8,56-60,61 
IGF-1 and mRNA translation  Strong  79,84-92 
 Myostatin   Strong  32,73,94,95 
 MicroRNA   More research needed  99,109,110 
 Apoptosis  More research needed  33,111,112 
 Telomere shortening in satellite cells  More research needed  124 
 oxidative stress  Strong  1,4,30,131-134 
Impaired muscle regeneration  Strong  4-8,141-143 
 satellite cells in aged muscle   Controversy   satellite cells in aged muscle: 
5,7-9,32,73,139,145-149 
No change in satellite cell in aged muscle: 11,150 
Impaired myoblast proliferation vs. myotube 
formation to cause impaired muscle repair 
Controversy  Impaired myoblast proliferation: 79,151 
Impaired myotube formation: 10,11,13,30,151,153 
 MRF   Controversy   MRF: 30,73,154,155 
/no change MRF: 6,142,160-162 
 Myostatin  Controversy   Myostatin: 32,73,158,159 Int. J. Biol. Sci. 2012, 8 
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/no change Myostatin: 161 
 Notch signaling  Strong  7,12,13,195 
 Wnt signaling  Controversy   Wnt signaling: 14-17,200,201 
 Wnt signaling:185,202,212,213 
 
 
a.  Intramuscular  fibrosis  and  adipose  tissue: 
With the prevalence of fibrosis and adiposity in aged 
skeletal muscle, it is of interest to determine if physi-
ological stimuli reduce fibrosis and intramuscular fat 
(25, 28, 214). In aged skeletal muscle of both human 
and  rodent  models,  exercise  training  decreases  in-
termuscular adipose tissue (214-216). There was a 7% 
increase in lean thigh tissue and 11% decrease in in-
termuscular adipose tissue in aged (> 55 yrs) subjects 
who performed a 12 wk resistance training program 
(214). Aged (23 mo) rats that performed life-long ex-
ercise had a 50% reduced muscle triglyceride count 
than sedentary controls (215). Aged (~ 76 y) subjects 
who  participated  in  a  complete  exercise  program 
(aerobic, muscle strength, flexibility and balance) did 
not report any increases in intramuscular fat content, 
while subjects who did not exercise had an 18.4% in-
crease in muscle fat infiltration (216). Exercise training 
has the potential to prevent the age-associated accu-
mulation  of  fibrosis  and  adipogenicity  in  skeletal 
muscle. 
b. Pro-inflammatory cytokines TNFα and IL-6: 
Although  contentious,  reports  suggest  that 
age-associated  elevations  in  the  pro-inflammatory 
cytokines TNFα and IL-6 within aged skeletal muscle 
may contribute to sarcopenia by inducing muscle at-
rophy and promoting protein degradation and ROS 
accumulation.  Anti-inflammatory  medications  are 
one countermeasure employed to combat the chronic 
inflammatory response that accompanies sarcopenia. 
Little  is  known  about  the  benefits  of  exercise  as  a 
non-pharmacologial  tactic  against  the 
pro-inflammatory cytokines TNFα and IL-6 (35). An 
acute bout of exercise increases TNFα and IL-6 levels 
in young and aged skeletal muscle (46, 47, 217, 218). 
For example, serum IL-6 levels can increase 100-fold 
during exercise (217). Following an acute bout of ex-
ercise,  there  is  elevation  of  pro-inflammatory  cyto-
kines in aged subjects, but to a lesser degree than in 
young subjects (47, 218). Young subjects had greater 
increases in plasma IL-6 than aged subjects up to four 
days after performing heavy eccentric resistance ex-
ercises  (218).  At  72h  post-downhill  running,  TNFα 
mRNA in VL was elevated 2.8 fold for young (23 – 35 
y) subjects, while TNFα mRNA in aged subjects (66 – 
78 y) VL was elevated only 1.8 fold (47).  
The  exercise-induced  elevation  of 
pro-inflammatory cytokines in aged muscle in an al-
ready  inflamed  environment  suggests  that  an  acute 
bout of physical activity is not beneficial to sarcopenic 
patients. The exercise-induced release of TNFα may 
exacerbate muscle injury (219). Inhibiting TNFα with 
cV1q antibody in dystrophic mice (mdx mice) resulted 
in  a  decrease  in  muscle  necrosis  at  24h  following 
wheeling running exercise (219). However, it should 
be noted that there are inconsistencies in the data on 
the effect of age and exercise on TNFα and IL-6 s more 
research is needed to better understand their interac-
tion following an acute bout of exercise (36).  
It is interesting to report that, contrary to what is 
seen  following  a  single  bout  of  exercise,  consistent 
exercise  training  may  elicit  a  decrease  in 
pro-inflammatory cytokines (220-224). Epidemiologi-
cal studies report that aged (70 – 79y) subjects with 
higher levels of daily physical activity had lower lev-
els of plasma TNFα and IL-6 (220). Exercise-induced 
attrition of TNFα and IL-6 within aged skeletal muscle 
may  prevent  their  deleterious  effects,  resulting  in 
preservation of skeletal muscle mass and function. It 
is  plausible  to  suggest  that  daily  physical  activity 
(aerobic,  strength,  flexibility)  may  be  a  good  coun-
termeasure to sarcopenia and age-associated chronic 
inflammation (220). A cycle ergometry exercise pro-
gram decreased TNFα in aged subjects (223). A year of 
physical  activity  resulted  in  an  8.5%  decrease  in 
plasma IL-6 levels in aged (70 – 89y) subjects (224). A 
12-week cardiac rehabilitation program resulted in a 
decrease in IL-6 and an increase in anti-inflammatory 
marker IL-10 in aged (64 y) subjects (221). An exercise 
training  program  consisting  of  both  aerobics  and 
strength training resulted in a 50% decrease in TNFα 
and IL-6 mRNA in aged (~ 69 y) subjects (222). Be-
cause TNFα and IL-6 may be associated with sarco-
penia, the data supporting a reduction in TNFα and 
IL-6 levels associated with long-term exercise training 
demonstrates  the  potential  of  physical  activity  as  a 
therapeutic  strategy  in  the  treatment  of  sarcopenia. 
Further research is needed to determine the relation-
ship between exercise and TNFα and IL-6, and their 
roles in sarcopenia. 
c.  Sex  hormones:  Sex  hormones  independently 
and  in  orchestration  with  other  factors,  play  im-
portant  roles  in  maintaining  skeletal  muscle  mass 
integrity, and preventing the accumulation of intra-
muscular fat (1, 8, 53, 54). With aging, there is a de-
crease  in  sex  hormone  levels  which  increases  intra-Int. J. Biol. Sci. 2012, 8 
 
http://www.biolsci.org 
747 
muscular adipose tissue accumulation and decreases 
skeletal muscle mass, thereby contributing to sarco-
penia (1, 8, 53, 54, 191). Treatment with sex hormone 
supplements  has  not  consistently  demonstrated  re-
covery or delay of sarcopenia, therefore other tactics 
to replenish testosterone and estrogen levels in aged 
skeletal muscle need to be considered (54, 63, 64). One 
potential strategy to increase sex hormone levels in 
aged  skeletal  muscle  is  physiological  stimuli  (225, 
226). Total testosterone increased in aged (62 y) men 
who  performed  a  10  wk  power-training  program 
(226). 17-estradiol levels increased in overectomized 
rats that performed 12 wks of treadmill training rela-
tive  to  overectomized  controls  (225).  Training  pro-
grams have also been shown to counteract the nega-
tive effects of decreased sex hormone levels in aged 
skeletal muscle, both in the presence and absence of 
hormone replacement therapy (HRT) (62, 227). Mid-
dle-aged  women  (50  –  57  years)  who  performed  a 
one-year resistance training program  in conjunction 
with  HRT  saw  positive  results  in  skeletal  muscle 
performance  (62).  Hormone  therapy  treatment  may 
not be essential for negating the detrimental effects of 
depleted  sex  hormones  and  sarcopenia.  Postmeno-
pausal women between the ages of 55 – 75 y who were 
not  on  HRT  performed  a  3  mo  resistance  training 
program and found a decrease in percent body fat, an 
increase in lean body mass and an increase in physical 
performance (227). Physiological stimuli, which may 
take the form of endurance or resistance training, can 
replenish  depleted  sex  hormones  in  aged  skeletal 
muscle, and may be considered an effective interven-
tion in the treatment of sarcopenia. 
d. Skeletal muscle function: It is known that with 
sarcopenia, there is a decrease in aged muscle func-
tion  that  is  often  observed  following  exposure  to 
physiological stimuli(228). Aged (~78 y) subjects ex-
posed to a injurious plantar flexion exercises experi-
enced a 26% drop in isometric plantar flexion maxi-
mal  voluntary  contraction  (MVC)  torque,  and  pro-
duced 38% less peak power compared to young (~ 24 
y) subjects (229). In addition, aged (~ 66 y) women 
who performed an acute bout of knee extensions ex-
perienced  a  27%  decrease  in  eccentric  1  repetition 
maximum (1 RM) compared to a 10% decrease in 1 
RM in young (~ 23 y) women (230). Using a mouse 
model, one bout of an in situ lengthening contraction 
protocol  resulted  in  greater  force  deficits  in  aged 
(27-34 mo) muscle relative to young (5-6 mo) muscle 
(231).  Likewise,  following  two  bouts  of  in  vitro 
lengthening  contractions  of  the  extensor  digitalis 
longus (EDL) muscle, there was a greater force deficit 
reported in aged (24 – 25 mo) mouse muscle (~ 27.4%) 
than young (3 – 4 mo) mouse muscle (~ 21.5%) (232). 
In addition to loss of function, aged muscle also 
experiences a delay in recovery of force production 
following  injurious  physiological  stimuli  (233,  234). 
Young mouse muscle exposed to a bout of injurious in 
situ  lengthening  contractions  had  complete  restora-
tion of muscle force production 28 days post-exercise, 
while  aged  mice  muscle  demonstrated  only  84%  of 
force production 28 and 60 days post-exercise (233). 
Following injurious in situ lengthening contractions, 
adult (6 mo) rat TA muscle contractile properties re-
covered in 5 days, while aged (32 mo) rat TA did not 
recover until 14 days post-exercise (234).  
A  single  bout  of  physiological  stimuli  is  not 
beneficial in improving age-associated loss of muscle 
force production, but multiple exercise bouts are con-
sidered  to  have  beneficial  effects  on  sarcopenia,  in-
cluding  recovery  of  aged  muscle  force  production. 
There was a 174% increase in muscle strength, a 9% 
increase in mid-thigh cross sectional area and a 48% 
increase in gait speed in aged (~ 90 y) subjects who 
performed an 8 week high-intensity resistance train-
ing  program  (235).  Following  a  24  wk  resistance 
training  program,  quadricep  muscle  strength  and 
cross sectional area increased by 29% and 7% respec-
tively in aged men (62 – 77 y) (236). Similar muscle 
strength findings were reported by Verdijk et al. who 
found that aged (~72 y) male subjects experienced a 
25%  -  30%  increase  in  quadriceps  muscle  strength, 
and a 6% - 9% increase in quadricep muscle mass fol-
lowing a 12 wk resistance training program (237).  
Repeated  bouts  of  physiological  stimuli  also 
produced protection against muscle injury and expe-
diated recovery of force production (230, 234, 238). A 
training effect was observed in aged (32 mo) rat TA 
muscle that was exposed to two bouts of injurious in 
situ  lengthening  contractions.  There  was  less  force 
deficit after the second bout of lengthening contrac-
tions compared to that experienced after the first bout 
of lengthening contractions (234). Henwood et al. as-
sessed  muscle  function  recovery  following  training, 
de-training and re-training of muscles. Aged (65 – 84 
y) subjects experienced 24 wks of training of either 
high velocity power training (HV) or strength training 
(ST)  followed  by  24  wks  of  de-training  and  then  a 
subsequent 12 wks re-training protocol. Isometric and 
dynamic muscle strength and muscle power increased 
after the initial 24 wk HV and ST training programs. 
There was a minimal loss of muscle function (strength 
and  power)  following  the  de-training  period,  sug-
gesting  that  the  initial  training  protocol  offered  ad-
aptation  and  protection  of  muscle  strength  (238). 
Likewise,  aged  (~  66  y)  women  who  performed  an 
injurious bout of knee extension exercise following a 
12  wk  knee  extension  resistance  training  program Int. J. Biol. Sci. 2012, 8 
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experienced  no  significant  edema  (muscle  injury 
marker) relative to young (~ 23 y) women, suggesting 
that  the  resistance  training  produced  protection 
against muscle injury (230).  
Although  physiological  stimuli  training  im-
proves muscle strength and adaptation in aged mus-
cle, there is still a delay in recovery in aged muscle 
relative  to  young  skeletal  muscle  (234,  239,  240). 
Young (21 – 27 y) and aged (61 – 74 y) male subjects 
were  exposed  to  whole  leg  immobilization  for  two 
wks  and  subsequently  performed  lower  body  re-
sistance exercises for 4 wks. After 4 wks of re-training, 
young subjects showed a significant increase in their 
quadricep muscle volume (~ 8.2%) while aged quad-
riceps muscle volume increased only ~ 3.8% (240). In 
rodent models, reports show that there is a delay in 
muscle  force  recovery  in  aged  muscle  relative  to 
young  muscle,  but  that  aged  muscle  does  indeed 
adapt (234, 239). Brooks et al. exposed young (7 mo) 
and aged (22 mo) mice dorsi flexors to a 4 wk in situ 
muscle lengthening training protocol, and found that 
while  young  mice  experienced  adaptation  and  no 
significant force deficit, aged mice had a delay in ad-
aptation  such  that  it  took  6  wks  for  force  recovery 
(239).  
It should be noted that some investigators report 
that training has deleterious effects on aged muscle 
function (228, 241, 242). Cutlip et al. exposed young (~ 
6 wks) and aged rats (~ 30 mo) to a 4.5 wk training 
protocol  of  low-velocity  intermittent  in  vivo 
stretch-shortening  muscle  contractions  of  the  dorsi 
flexors.  The  training  program  increased  isometric 
force production 25% in the young TA, but there was 
a 34% decrease in TA isometric force production in 
the aged TA. In addition, while the exercise protocol 
significantly  increased  the  wet  muscle  mass  of  the 
young TA, there was no change in wet mass of the 
aged TA (228). Although there may be differing re-
ports  on the effects of training on function of aged 
muscle, the majority of evidence suggests that multi-
ple bouts of physiological stimuli increase force pro-
duction and recovery of force in aged muscle, and are 
beneficial in the prevention and treatment of sarco-
penia.  
e. Muscle fibers and motor units: With sarcope-
nia there is a preferential loss of Type II muscle fibers 
(25, 31, 66, 67, 243). Physiological stimuli may have 
the potential to prevent age-associated loss of muscle 
fibers, specifically Type II muscle fibers (31, 237, 244, 
245). Verdijk et al. found a ~ 28% increase in Type II 
muscle fibers in aged male subjects (~72 y) who per-
formed  a  12  wk  resistance  training  program  (237). 
Type IIA plantaris muscle fibers increased in aged (24 
mo) rats that performed a 12 wk endurance treadmill 
program  (244).  Resistance  training  may  be  a  more 
effective  physiological  stimulus  model  than  endur-
ance  training  to  prevent  the  loss  of  Type  II  muscle 
fibers (31, 245). Klitgaard et al. found that aged sub-
jects who strength trained for 12 – 17 years possessed 
muscle fiber morphology more similar to young sed-
entary subjects than aged subjects who were swim-
mers  or  runners  (31).  Strength  training  may  be  a 
physiological  stimulus  that  protects  aged  skeletal 
muscle from sarcopenia (31, 67, 237, 245).  
Another variable that contributes to the loss of 
muscle fibers with age is alterations in motor units. 
There  are  decreases  in  motorneuron  number,  fast 
twitch motor unit number and motor unit recruitment 
(66, 70, 73). Endurance training may be beneficial in 
counteracting the deleterious effect of motor unit ad-
aptation that is associated with aging (246). Aged (~ 
65 y) male runners possessed comparable TA motor 
unit quantity to young (~25 y) controls and signifi-
cantly more motor units than aged sedentary subjects 
(246). Strength training has also been shown to im-
prove motor unit function in aging muscle (72, 247). 
Leong et al. reports increased motor unit discharge in 
the  rectus  femoris  of  aged  (67-79  y)  men  who  re-
sistance  trained  (247).  Similarly,  a  6  wk  resistance 
training program resulted in a 40% increase in motor 
unit discharge of the VL of aged (~77 y) adults (72). 
Chronic  physiological  stimuli  appear  to  rejuvenate 
impaired motor unit function in aged skeletal muscle. 
f. Protein synthesis/degradation balance: Physi-
ological  stimuli  consisting  of  a  variety  of  exercise 
modes may be a form of treatment that can counteract 
the protein imbalance in aging skeletal muscle (77, 93, 
248-255).  An  acute  bout  of  leg  extension  resistance 
exercise increases the fractional synthesis rate (FSR) of 
mixed  muscle  protein  and  myofibrillar  protein,  as 
well  as  amino  acid  transporter  expression 
(LAT1/SLC7A5,  CD98/SLC3A2,  SNAT2/SLC38A2, 
PAT1/SLC36A1,  and  CAT1/SLC7A1)  in  the  VL  of 
aged men (248, 251, 253). Exercise training programs 
also  increase  protein  synthesis  in  aged  muscle  (77, 
249, 250, 252, 254, 255). Using leucine incorporation as 
a marker for protein synthesis, leg extension training 
also increases protein synthesis in VL of aged male 
subjects (77, 255). Also, training programs consisting 
of  endurance,  strength,  flexibility  and  balance  exer-
cises increase mixed muscle protein FSR in aged sub-
jects by 50% (254). (Furthermore, novel techniques of 
administrating either amino acid supplementation or 
blood  flow  restriction  (reducing  blood  flow  to  the 
exercising muscle) in conjunction with resistance ex-
ercise have also been shown to increase protein syn-
thesis in aged muscle (93, 249, 250, 252). During the 
three hours post-blood flow restriction and exercise Int. J. Biol. Sci. 2012, 8 
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combination treatment, there was a 56% increase in 
muscle protein synthesis in the VL of aged men (mean 
70 ys) (250).  
g. IGF-1 and mRNA translation: The finding that 
aged muscle responds to physiological stimuli by in-
creasing  protein  synthesis  supports  the  notion  that 
aged muscle possesses the capability to manufacture 
protein in response to certain stimuli. There is a strong 
correlation between loss of muscle mass and attrition 
of IGF-1 and GH levels in aged skeletal muscle (80, 81, 
85). Physiological stimuli may be an effective strategy 
to increase IGF-1 and GH levels in sarcopenic muscle 
(256-259). Resistance training increases IGF-1 expres-
sion  (including  the  isoforms  IGF-1Ea,  mecha-
no-growth factor [MGF]) in aged subjects  (256-259). 
There was a 500% increase in IGF-1 expression in aged 
(~ 87 y) men exposed to a 10 wk resistance training 
program (257). Hameed et al. examined the effect of 
GH  administration  with  and  without  resistance 
training on expression of IGF-1 isoforms (MGF and 
IGF-IEa) in aged (74 y) men. Resistance training alone 
increased mRNA levels of MGF (163%), IGF-IEa (68%) 
and IGF-IEb (75%). Resistance training in combination 
with GH administration resulted in greater increase of 
MGF mRNA (456%) and IGF-IEa mRNA (167%) (258). 
Hameed’s results indicate that physiological stimuli 
alone can increase IGF-1 isoforms, but administration 
of  GH  further  elevates  IGF-1  isoforms.  Hameed’s 
group also examined the effect of aerobic exercise on 
IGF-1 isoforms and found that eccentric cycling (re-
verse pedaling) increases MGF mRNA in both young 
(20-27  y)  and  aged  (67  –  75  y)  quadriceps  muscles 
(260). 
Since insulin is known to up-regulate IGF-1 ac-
tivity,  there  may  be  an  age-associated  correlation 
between insulin and IGF-1 in which a decrease in in-
sulin sensitivity is associated with a decrease in IGF-1 
activity. It is plausible to suggest that treating insulin 
insensitivity  in  aging  muscle  with  physiological 
stimuli could re-establish  IGF-1 levels (261). Insulin 
signaling and sensitivity was improved in aged rats 
that performed an acute bout of swimming exercise 
(262).  Resistance  training  also  improves  insu-
lin-dependent  glucose  uptake  in  skeletal  muscle  of 
aged subjects (263). These findings suggest that exer-
cise may be effective in restoring IGF-1 isoforms in 
aged  skeletal  muscle.  Because  IGF-1  is  critical  to 
muscle  growth  and  protein  synthesis,  IGF-1  may 
prove to be an effective countermeasure to sarcopenia. 
Studies have examined the relevance of physio-
logical  stimuli  to  the  improvement  of  translational 
efficiency  in  aged  skeletal  muscle  (249-251).  mTOR 
signaling components including mTOR phosphoryla-
tion and phosphorylation of S6K1 are elevated in aged 
muscle exposed to leg resistance exercise (249). The 
treatment combination of blood flow restriction and 
exercise also increases mTOR components including 
mTOR phosphorylation, phosphorylation of S6K1 and 
increased S6 ribosomal protein in aged muscle (250). 
This  treatment  combination  may  be  beneficial  in 
counteracting  sarcopenia  because  it  induces  muscle 
protein synthesis and mTOR signaling (249, 250).  
Although aged skeletal muscle has the ability to 
generate proteins and activate mTOR signaling, this 
potential  is  diminished  relative  to  young  skeletal 
muscle  (245,  251,  264,  265).  There  was  less  leucine 
incorporation  and  phosphorylation  of  p70rS6k  and 
4EBP1 in aged (~ 70 y) men relative to young men 
who performed one bout of resistance exercise (251). 
Mayhew  et al.  report  a  60%  increase  in  phosphory-
lated  Akt  in  young  muscle  compared  with  39%  in 
aged muscle following a single bout of resistance ex-
ercise  (245).  After  28  days  of  plantaris  overload, 
mTOR phosphorylation was elevated by 44% and 35% 
in young (6 mo) rats and aged (30 mo) rat muscle re-
spectively.  In  addition,  ribosomal  protein  S6  phos-
phorylation  increased  114%  and  24%  in  young  and 
aged plantaris, respectively, after overload (265). The 
accumulation  of  studies  support  the  notion  that 
physiological  stimuli  such  as  overloading  elevates 
mTOR signaling and improves translational efficiency 
in aged skeletal muscle. 
h. Myostatin: Physiological stimuli may further 
enhance protein synthesis by inhibiting myostatin, an 
inhibitor of protein synthesis (67, 266-270). An acute 
bout  of  exercise  decreases  myostatin  levels  (67, 
267-269).  Myostatin  mRNA  in  the  VL  decreased  in 
aged (60-75 y) subjects who performed a single bout 
of  resistance  exercise  (268).  Training  exercises  also 
decrease  myostatin  levels  (266,  270).  Myostatin 
mRNA in aged VL muscle decreased 37% following 9 
wks of leg extensions training (270). Following three 
bouts  of  resistance  training,  myostatin  mRNA  de-
creased  and  myostatin-inhibitor  follistatin  –like 
mRNA  increased  in  aged (68  y)  subjects  relative  to 
young (28 y) subjects (266). In summary, physiological 
stimuli  influence  proteins  and  signaling  pathways 
that  promote  protein  synthesis  in  the  aged  muscle, 
and may be a useful strategy to combat sarcopenia. 
i.MicroRNA:  There  is  evidence  to  suggest  that 
the  novel  post-transcriptional  inhibitors,  mus-
cle-specific microRNA (miRNAs) are critical for mus-
cle  repair.  Given  the  altered  expression  of  certain 
muscle-specific  miRNAs  in  aged  skeletal  muscle, 
there is an emerging concept that miRNA levels may 
predict sarcopenia (Table 2) (109, 110, 271). Research 
is  ongoing  to  determine  the  effect  of  physiological 
stimuli on young and aged skeletal muscle miRNA Int. J. Biol. Sci. 2012, 8 
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expression (98, 108, 110, 272, 273). Drummond et al. 
reported discrepancies in the changes in expression of 
primary  miRNA  (pri-miRNA)  and  mature  miRNA 
(miR) between young (~ 29 y) and aged (~ 70y) VL of 
subjects that performed a single bout of leg-extension 
exercise. pri-miRNA -206 increased in both young and 
aged  VL  muscle,  however  pri-miRNA  –  1-2,-133a-1, 
and  -133a-2  and  miR-1  decreased  in  young  muscle 
only (108). Using a rodent plantaris overload model, 
McCarthy  et al. reported  similar  findings  to  Drum-
mond et al. in regards to physiological stimuli induc-
ing a decrease in miR-1 and an increase in pri-mRNA 
206 expression in young muscle (98, 108). Conversely, 
McCarthy’s group reported that plantaris overloading 
increased  pri-miRNA  1-2  and  133a-2  in  muscle  and 
Drummond’s group reported that resistance exercise 
decreases these factors. In addition, while McCarthy et 
al.  reported  that  plantaris  overload  did  not  alter 
pri-miRNA 133a-1 expression in muscle, Drummond et 
al. saw a decrease in pri-miRNA 133a-1 in muscle fol-
lowing resistance exercise (98, 108). 
There are also differing reports of miR expres-
sion  following  endurance  exercise  (272,  273).  While 
MCarthy et al. and Drummond et al. found that both 
resistance exercise and overloading models decreased 
miR-1  in  muscle,  Safdar  et al.  found  that  a  bout  of 
endurance  exercise  increased  miR-1  expression  (as 
well as miR 187) in mouse quadriceps muscle (98, 108, 
273). However, Nielson et al. found a decrease in miR 1 
expression in VL of subjects who performed a 12 wk 
endurance training program (272). There are numer-
ous conflicting reports on the effect of physiological 
stimuli on miR and pri-miRNA expression in skeletal 
muscle. One potential explanation for the differences 
in expression of muscle pri-miRNAs or miRs follow-
ing physiological stimuli is the assortment of physio-
logical  stimuli  models  used  (overload  hypertrophy 
model, resistance exercise, endurance exercise) which 
may  induce  varying  degrees  of  miR  or  pri-miRNA 
up-regulation.  These  conflicting  reports  underscore 
the need for more research on the effect of various 
modes  of  physiological  stimuli  on  miRNA  and 
pri-miRNA  expression  in  young  and  aged  skeletal 
muscle. Such studies will generate a more complete 
understanding  of  the  importance  of  miR  in  aging 
skeletal muscle.  
 
 Table 2. The effect of physiological stimuli on micro-RNA/pri- RNA expression. 
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j.  Apoptosis:  Because  sedentary  conditions  are 
known  to  up-regulate  skeletal  muscle  apoptosis,  it 
appears worthwhile to study the effect of exercise on 
apoptotic-associated  loss  of  muscle  mass.  An  acute 
bout of exercise in rodent skeletal muscle resulted in 
increased  DNA  fragmentation  and  apoptotic  nuclei 
(274, 275). However, in human models, young  sub-
jects who performed a bout of cycle ergometry did not 
display  any  alterations  in  pro-apoptotic  proteins, 
caspase activity, DNA fragmentation or anti-apoptotic 
protein  activity  (276).  The  differences  in  apoptotic 
responses  following  a  single  bout  of  physiological 
stimuli could be related to species, the capacity of the 
specific stimulus to incur or a variety of other reasons. 
Consequently, more research is needed to determine 
the effect of an acute bout of exercise on apoptosis in 
both young and aged skeletal muscle. 
Multiple bouts of physiological stimuli suppress 
apoptosis in both young and aged skeletal muscle (33, 
114, 275, 277). In addition to increasing the expression 
of apoptosis inhibitor ARC by 38%, an 8 wk tread-
mill-training  program  increased  anti-apoptotic  pro-
tein  XIAP  and  decreased  DNA  fragmentation  in 
young rodent skeletal muscle (277). A 12 wk tread-
mill-training program in aged (24 mo) rats decreased 
DNA  fragmentation  and  Bax  expression  and  de-
creased caspase-3 activity by 95% (114). In addition, 
there was a decrease in DNA fragmentation and Bax 
levels in the patagialis wing muscle of aged (~ 48 mo) 
Japanese quail exposed to a loading training protocol 
(278). These findings suggest that an appropriate ex-
ercise-training  program  may  attenuate  age-related 
skeletal muscle apoptosis, and could be considered a 
countermeasure for sarcopenia. 
k.  Telomere  length:  Telomere  shortening  is  a 
marker  for  age-associated  cellular  senescence  and 
may be associated with sarcopenia (124, 126). Chronic 
physiological stimuli such as life-long physical activ-
ity may delay telomere shortening (279-282). A study 
that  compared  leukocyte  telomere  length  between 
physically active and sedentary twins showed a direct 
correlation  between  physical  activity  and  leukocyte 
telomere  length.  Leukocyte  telomere  lengths  of  the 
most active were ~ 200 nucleotides longer than the 
leukocyte telomere lengths of the least active subjects 
(280). Lullow et al. found that aged (50 – 70 y) subjects 
with  high  exercise  energy  expenditure  displayed 
longer telomere lengths than subjects with low exer-
cise energy expenditure (282). Ponsot et al. reported no 
differences in minimum telomere length in TA satel-
lite cell DNA between young (~ 25 y) and aged (~ 75 
y)  recreationally  active  subjects  (279).  Similarly,  en-
durance-trained aged subjects (55 – 72 y) had leuko-
cyte telomeres ~ 900 base pairs longer than sedentary 
age-matched controls, and were not significantly dif-
ferent in length from those of young (18 – 32 years) 
exercised  subjects  (281).  These  data  suggest  that 
moderate physical activity may have a protective ef-
fect against age-associated telomere shortening, and 
may have therapeutic potential for the treatment of 
sarcopenia. 
l. Oxidative stress: Certain types of physiologi-
cal  stimuli  have  the  potential  to  decrease 
ROS-producing sources and may therefore be coun-
termeasures  to  sarcopenia.  Exercise  training  (either 
aerobic-  or  resistance-type  exercises)  appears  to  de-
crease oxidative stress in aged skeletal muscle, possi-
bly by elevating mitochondrial content and function 
(283-285).  A  12  wk  endurance-training  program  in-
creased mitochondrial content and activity (succinate 
oxidase activity and NADH oxidase activity) in aged 
(~67y)  subjects  (283).  In  mtDNA-mutated  mice  that 
express  progeroid  aging  (characterized  by 
age-associated mitochondrial dysfunction), a five-mo 
endurance  training  program  resulted  in  increased 
systemic mitochondrial biogenesis and oxidative ca-
pacity (285). There is decreased lipid peroxidation in 
serum  of  aged  (~  68y)  subjects  following  a  six-mo 
high resistance training program (286). A 14 wk re-
sistance  training  program  increased  mitochondrial 
ETC complex IV activity and decreased the oxidative 
stress marker 8-hydroxydeoxyguanosine (8-OHdG) in 
aged (~ 68y) subjects (284). Physiological stimuli also 
increase antioxidant activity and heat shock protein 
levels (284, 287). Parise et al. reported a 75% and 82% 
increase in copper zinc superoxide dismutase (CuZ-
nSOD) and catalase respectively in aged (~ 71y) sub-
jects who performed a 12 wk resistance training pro-
gram (288). Lastly, Naito et al. reported elevations in 
heat shock protein 72 in aged (23 mo) rats that per-
formed  a  10  wk  treadmill  training  program  (287). 
These studies suggest that physiological stimuli may 
be a beneficial countermeasure to decrease oxidative 
stress and elevate antioxidant expression in sarcope-
nic muscle. 
V. Effect of Physiological Stimuli on Muscle 
Regeneration and Notch and Wnt Signaling in 
Sarcopenic Muscle  
One  potential  effective  interventional  strategy 
for  impaired  repair  in  sarcopenic  muscle  is  physio-
logical  stimulation,  which  is  known  to  up-regulate 
regenerative  pathways  in  young  muscle  (289-294). 
Both  voluntary  free  wheel  and  resistance  wheel 
training increased satellite cell number in young (7 – 
10 wks) rats (294). There was a 5-fold increase in em-
bryonic  MHC  in  young  (5  –  8  wks)  mice  that  per-
formed a bout of downhill running (293). Since phys-Int. J. Biol. Sci. 2012, 8 
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iological  stimuli  activate  the  pathways  needed  for 
repair  in  young  muscle,  it  would  be  meaningful  to 
determine if exercise has the ability to positively im-
pact muscle repair mechanisms within aged muscle. 
For example, the effects of exercise on dysfunctional 
satellite cell regulation could be determined. 
a. Muscle regeneration: There is a wealth of evi-
dence  suggesting  that  physiological  stimuli  rescues 
aspects  of  impaired  muscle  regeneration  in  aged 
skeletal muscle (67, 125, 289-292, 295-299). Treadmill 
exercise  training  increases  satellite  cell  numbers  in 
aged  rats  (289,  291).  Following  13  wks  of  treadmill 
running, aged (15 – 17 mo) rats expressed increased 
MyoD-positive and Pax-7-positive satellite cells (289) 
Aerobic training also increases satellite cell numbers 
and MRFs in aged subjects (300). Following a 12 wk 
aerobic  training  protocol,  the  percentage  of  MHC  I 
mRNA expression increased from ~ 54% (at rest) to ~ 
61% (post training) in aged (~70 yrs) women subjects 
(300).  Resistance  training  exercises  elevated  satellite 
cell  numbers,  MHC,  MyoD,  and  myogenin  in  aged 
subjects (67, 292, 295, 298, 299). Mackey et al. reported 
that following 12 wks of resistance training, there was 
a 27% increase in NCAM + cells in VL of aged (~76 
yrs) subjects, suggesting that aged muscle has myo-
genic potential (298). Furthermore, using the stretch 
overload model in the latissimus dorsi (ADL) of aged 
(90 day) Japanese quail, Carson et al. reported there 
was an increase in number of BrdU- positive cells in 
myofibers relative to un-stretched controls (297). 
Although  physiological  stimulation  is  effective 
in reviving regeneration of aged skeletal muscle, there 
is a delay in the achievement of repair, and the mag-
nitude  of  repair  is  not  as  robust  as  seen  in  young 
muscle  (290,  291).  While  young  (~6  wks)  rats  com-
pletely recovered by one week after an acute bout of 
treadmill  running,  aged  (16  wks)  rats  continued  to 
show markers of muscle injury and repair at 2 weeks 
post-exercise  (291).  At  24h  post  injurious  eccentric 
knee  extensor  exercises,  young  (25  –  35  yrs)  males 
showed a greater elevation of NCAM+-cells than aged 
(60 – 75 yrs) males. However, it should be noted that 
the injurious exercise increased satellite cell number 
in the aged subjects (290). 
The  overwhelming  evidence  that  physiological 
stimuli  induce  muscle  repair  mechanisms  in  aged 
muscle provides strong support for the idea that ex-
ercise should be considered a practical intervention 
strategy to up-regulate the impaired cellular and mo-
lecular  mechanisms  of  aged  muscle  repair.  Physio-
logical stimuli may release systemic factors that are 
otherwise not present in aged muscle, and induce a 
rejuvenation  of  muscle  repair  in  sarcopenic  muscle 
(67, 125, 296). For example, exercise increases VEGF, 
which  is  known  to  be  important  for  muscle  repair, 
and is depleted in aged skeletal muscle (296). More 
research is needed to investigate the effect of physio-
logical stimuli on the delivery of factors that influence 
the  satellite  cell  niche  and  enhance  repair  of  aged 
skeletal muscle.  
b. Notch and Wnt signaling: Studying the influ-
ence of physiological stimuli on Notch and Wnt sig-
naling  could  be  a  novel  therapeutic  tactic  to  tackle 
impaired aged skeletal muscle repair that is associated 
with sarcopenia. As described above, Notch and Wnt 
are  critical  to  muscle  repair,  and  there  is  evidence 
suggesting that these pathways may be dysfunctional 
in  aged  muscle  (7,  12-17,  195).  As  described  in  the 
preceding sections of this review article, physiological 
stimuli,  through  a  variety  of  forms  of  exercise  and 
contraction-induced  injury  models,  release  factors 
that promote a pro-myogenic environment, and the 
rescue of dysfunctional repair of aged skeletal muscle. 
Physiological  stimuli  increases  Notch  and  Wnt  sig-
naling  in  young  muscle  models  (Figure  2)  (18-23). 
Downhill running and overload hypertrophy models 
increase  components  of  Notch  signaling  in  young 
skeletal  muscle  (18,  19).  Tsivitse  et  al.  reported  in-
creased  expression  of  Notch1  and  Delta1  in  mouse 
hindlimb muscles exposed to an acute bout of injuri-
ous  downhill  running  (18).  Treadmill  running  and 
overload  hypertrophy  models  decreased  GSK3β  ac-
tivity and increased canonical Wnt signaling in young 
skeletal muscle (20-22). Following plantaris overload, 
β-catenin, Frizzled 1 and Lef-1 mRNA levels increased 
suggesting that muscle growth stimuli activate Wnt 
signaling (21). 
It is clear that research looking at physiological 
stimuli  and  regulation  of  Notch  and  Wnt  signaling 
during skeletal muscle repair is promising in terms of 
therapeutic potential for the treatment of sarcopenia. 
Muscle contraction-induced injury models may 
be used as therapeutic tools to rescue the attenuated 
Notch and potentially dysfunctional Wnt signaling in 
aged skeletal muscle. Carey  et al. has demonstrated 
that both a single bout of resistance exercise, and a 12 
week resistance training program increased Notch 1 
and Hes 6 gene expression in VL of aged (60 – 75 y) 
males, suggesting that physiological stimuli may be a 
beneficial tool for rejuvenating attenuated Notch sig-
naling  (301).  Little  is  known  about  the  effects  of 
physiological  stimuli  on  Notch  and  Wnt  signaling 
pathways  in  aged  muscle,  but  because  exercise  is 
known to elevate circulating pro- myogenic factors, it 
appears  reasonable  to  consider  that  appropriate 
physiological stimuli may release systemic factors that 
return the balance of Notch and Wnt signaling in aged 
skeletal muscle. Using “global” forms of muscle inju-Int. J. Biol. Sci. 2012, 8 
 
http://www.biolsci.org 
753 
ry (exercise) that bring into play the influence of mul-
tiple  biological  systems  to  the  regenerative  process 
will help identify factors required for rejuvenation of 
impaired  myogenic  potential  in  aged  muscle.  For 
example,  factors  required  for  proper  regulation  of 
Notch and Wnt signaling during muscle repair may 
be identified. Further research will be required to de-
termine  if  physiological  stimuli  have  the  ability  to 
promote the proper orchestration of Notch and Wnt 
signaling for rejuvenating aged skeletal muscle repair.
 
 
 
Figure 2. The effect of aging & physiological stimuli on Notch and Wnt signaling during aged muscle repair.  
 
 
Conclusion 
It is well known that sarcopenia increases line-
arly with aging. It is also well known that the mecha-
nisms underlying the physiological manifestations of 
sarcopenia  are  multifactorial,  and  are  likely  to  be 
complex.  The  advancement  of  senescence  in  aged 
tissue has detrimental effects on skeletal muscle in-
cluding  loss  of  motor  nerves  and  muscle  fibers, 
apoptosis, telomere shortening, imbalance of protein 
synthesis  and  degradation.  All  of  these  factors  can 
contribute to decreased muscle quality (2, 8, 25, 28-30, 
32). Sarcopenia is also associated with increased in-
tramuscular adipose tissue, low-grade inflammation 
and  depleted  sex  hormone  levels.  Another  contrib-
uting factor to sarcopenia is the impaired ability of 
aged skeletal muscle to regenerate following injury. 
Causes of loss of myogenic potential with age may be 
related to intrinsic dysfunction of satellite cells, or to 
extrinsic  factors  in  which  the  environmental  mileu 
within the aged skeletal muscle is anti-myogenic (4-8). 
Recent evidence suggests that Notch signaling is im-
paired  and  Wnt  signaling  may  be  dysregulated  in 
aged  skeletal  muscle  (7,  12-14,  16,  17).  There  is  an 
abundance of evidence demonstrating that resistance 
and  endurance  training  re-balances  age-associated 
issues  that  cause  sarcopenia  including  decreasing 
intramuscular  adipose  tissue,  pro-inflammatory  cy-
tokine levels, oxidative stress and DNA fragmentation 
as well as delays/prevents telomere shortening and 
increases sex hormone levels, protein synthesis and 
growth  factors.  In  addition,  resistance  training  in-
creases Type II muscle fiber expression in aged mus-
cle  and  rejuvenates  impaired  motor  units.  Further-Int. J. Biol. Sci. 2012, 8 
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more,  exercise  may  positively  influence  the 
age-associated  muscle  repair  deficiencies  including 
enhancing  postnatal  myogenesis  through  increased 
satellite cell number, MRF expression, rescuing Notch 
signaling and regulating dysfunctional Wnt signaling. 
Consequently,  physiological  stimuli,  consisting  of  a 
variety of exercise models, may be an effective thera-
peutic tool in the fight against sarcopenia (67, 77, 125, 
269, 289-292, 295, 296, 298-300). Physiological stimuli 
release pro-myogenic systemic factors that may mimic 
a  young  skeletal  muscle  microenvironment.  This 
beneficial  aspect  of  exercise  may  rescue  the 
age-associated lack of Notch and Wnt orchestration 
during aged skeletal muscle repair. More research is 
needed to determine what factors in the environment 
of  aged  skeletal  muscle  contribute  to  sarcopenia.  A 
more  complete  understanding  of  the  mechanisms 
underlying  the  physiological  manifestations  of  sar-
copenia  will  facilitate  the  development  of  effective 
treatment  strategies  to  combat  this  debilitating  dis-
ease.  
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